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Chapter 1 
Introduction 
 Over the last twenty years, genetic companies have been increasing the genetic 
potential of sows to produce larger litters. The thought is that if the sow can produce 
more marketable pigs per year, then pork production will be more profitable for pork 
producers. However, although genetic selection for larger litters is beneficial, it also 
causes challenges for producers. An increase of one piglet per litter is associated with a 
30 to 50 gram reduction in average piglet birth weight (Opschoor et al., 2010). Not only 
is there a reduction in average birth weight, but there is an increase in variability of birth 
weights in genetically superior, highly prolific sows (Wolf et al., 2008; Ashworth, 2013). 
Increasing litter size also increases the number of pigs born weighing less than 1 kg (Holl 
and Long, 2006; Kohler and Bierman, 2014). Piglets born below the average pig birth 
weight in a litter have a greater likelihood of not surviving through weaning. Piglets that 
weigh between 0.68 and 0.90 kg at birth have a 64% survival rate compared to piglets 
that weigh more than 1.36 kg at birth, which have a 95% survival rate (Holl and Long, 
2006). System-wide benefits of increased litter size are limited due to these production 
losses and inefficiencies (Holl and Long, 2006) because they increase costs due to pigs 
not surviving to market weight, which include increased feed cost and medications, and 
the loss of pigs born that do not survive to market weight. Therefore, selection for 
increased litter size may not be beneficial unless measures are implemented to improve 
the survival of low-birth-weight piglets (Milligan et al., 2002a). 
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 An analysis of sow farm productivity from 2005 through 2010 shows how genetic 
selection for larger litters has affected swine production (Knauer and Hostetler, 2013). 
From 2005 to 2010, total born increased by 1.21 pigs per litter and pre-weaning mortality 
increased from 13.7% to 14.8%. Similarly, from 2011 to 2016, total born continued to 
increase by 0.3 pigs per litter. Over this same period, pre-weaning mortality rose from 
15.5% in 2011 to 17.3% in 2016 (Stalder, 2018). The increase in pre-weaning mortality 
observed during this time may explain why the number of pigs weaned has not increased 
as rapidly as the total number pigs born, with 10.2 pigs weaned per litter in 2011 and 10.3 
pigs weaned per litter in 2017 (Stalder, 2013; Stalder 2018). If pre-weaning mortality 
could be reduced, then number of pigs weaned per litter could increase similar to the 
trend of increased total pigs born per litter. 
 Babcock Genetics conducted a trial to determine the effects of piglet birth weight 
on farm profitability (Kohler and Bierman, 2014). They found that large differences in 
profitability occur from only minimal changes in variability of birth weight. For example, 
a litter with 12 piglets has a mean birth weight of 1.45 kg and a litter with 10 piglets had 
a mean birth weight of 1.63 kg.  The increase of 0.18 kg in mean piglet birth weights in 
the 10 piglet litter compared to the 12 piglet litter resulted in an increase in overall 
profitability of $20.66 (Kohler and Bierman, 2014). In addition, profitability can increase 
if the number of pigs marketed/year increases, but only if within litter birth weight 
variation is unchanged (Kohler and Bierman, 2014). If birth weight variation increases, 
there may be more piglets born below the 1 kg birth weight threshold, resulting in a 
higher pre-weaning mortality. Therefore, variation in birth weights of large litters can 
cause producers to lose money.  
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 A potential reason for elevated pre-weaning mortality and increased incidence of 
low birth weight pigs could be an increased incidence of intrauterine growth retardation 
in these large litters. Pigs exhibit the most extreme naturally occurring fetal growth 
restriction among litter bearing species (Wu et al., 2006).  Many litters contain at least 
one piglet that is considerably smaller than its littermates with some of these piglets 
weighing as little as 30% of the largest littermate (Ashworth, 2013). This lack of 
uniformity in litter birth weights creates a challenge for producers. High piglet birth 
weight variation within litters is often associated with increased pre-weaning mortality, 
variable piglet weights at weaning, and a poorer post-weaning growth performance 
leading to economic losses and reduced production efficiency (Campos et al., 2012; Yuan 
et al., 2015). These piglets will also take longer to reach market weight compared to 
larger littermates which increases production costs.   
 Intrauterine growth retardation will remain a significant problem to the animal 
industry until interventions are researched and adopted by producers (Wu et al., 2006). 
Being able to understand the mechanisms behind this phenomena and potential solutions 
to counteract the effects of IUGR and low birth weight pigs in production systems is 
important. Researchers have begun to evaluate different nutritional options for potential 
solutions but have obtained varying results. This is why research on this matter needs to 
continue to be able to find a solution for swine producers to employ.  
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Chapter 2 
Literature Review 
Intrauterine growth retardation and low birth weights 
 Intrauterine growth retardation (IUGR) is defined as impaired growth and 
development of the mammalian embryo, fetus, or its organs during pregnancy (Wu et al., 
2006). Intrauterine growth retardation may be considered a natural mechanism to protect 
the dam in cases of undernutrition. However, IUGR may not be beneficial for survival, 
optimal growth performance of the progeny, or efficiency of pork production. 
Intrauterine growth retardation affects many livestock species, but it is most severe in 
pigs (Ashworth, 2013).  
 In swine, uterine capacity limits fetal growth (Wu et al., 2006). As litter size 
increases, available nutrients for each fetus decrease due to increased fetal competition. 
This competition and inadequate supply of nutrients can cause suboptimal fetal 
development and consequently, lower birth weight and higher within-litter birth weight 
variation.  A growth-retarded pig fetus is associated with a smaller placenta which has 
less blood flow due to less dense vasculature compared with placentae that support 
normal fetuses (Ashworth, 2013).  
 Often, IUGR piglets or low birth weight piglets are referred to as runt pigs. Runts 
have been defined in the scientific literature as piglets born weighing less than 1 kg or 
having a birth weight less than two-thirds of the litter’s average birth weight (Perry and 
Rowell, 1969; Quiniou et al., 2002). These smaller piglets can weigh less than half of the 
body weight of their larger littermates. There is a positive correlation between piglet 
survival to weaning and body weight at birth (Leenhouwers et al., 2002). This association 
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occurs because low birth weight piglets have difficulty competing with their heavier 
littermates for colostrum and milk (Leenhouwers et al., 2002; Fix et al., 2010), which 
impairs their development. 
 Researchers found that IUGR and small birth weight fetuses can be identified as 
early as day 30 of gestation (van der Lende et al., 1990; Finch et al., 2002). Distribution 
of fetuses in body weight categories at 27 to 35 days post-mating is similar to body 
weight distribution of piglets at birth suggesting that disparities in birth weight are 
established very early in gestation (van der Lende et al., 1990). Restricted fetal growth 
early in gestation, before physical uterine capacity is reached, may suggest that fetal 
location in the uterine horn is not a determining factor in the occurrence of IUGR, but 
more likely involves placental and fetal development. Even though IUGR is apparent 
early in pregnancy, it worsens as fetuses develop and physical crowding can then become 
a factor that magnifies the differences in body weights among fetuses in utero.  
 There are conflicting ideas on whether birth weight and fetal development depend 
on location within the uterine horn. Perry and Rowell (1969) noted that smaller fetuses 
were generally located closer to the middle of the horn, with larger fetuses located near 
the ends of the horn. However, these observations were noted only when the uterine horn 
contained six or more fetuses. Other studies have shown that runts can be found at any 
position in the uterine horn (Wu et al., 2006), and gilts slaughtered during pregnancy 
demonstrated no relation between uterine location and weight of each fetus (van der 
Lende et al., 1990).  
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Effects of fetal growth retardation and low birth weight pigs  
 Fetal growth retardation can cause negative effects on neonatal survival, post-
natal growth (Quiniou et al., 2002) and feed efficiency (Powell and Aberle, 1980), body 
composition of offspring (Hegarty and Allen, 1978; Powell and Aberle, 1980), meat 
quality of offspring (Gondret et al., 2005), and long-term pig health (Rooke and Bland, 
2002; Le Dividich et al., 2005).  
 In terms of survival, small piglets have a disadvantage compared to their heavier 
littermates, and this disadvantage is exacerbated in large litters and litters from older 
sows (Milligan et al., 2002b). Litters with high variation in birth weight had more deaths, 
especially if the litter’s mean birth weight was 1.05 kg or less (Milligan et al., 2002b). 
High neonatal mortality in livestock is associated with low birth weight. This is due to 
correlations found between birth weight and behavioral maturity of the animals 
(Ashworth, 2013). Piglets with birth weights below 1 kg are at a higher risk of pre-
weaning mortality than piglets born weighing more than 1 kg (Zeng et al., 2018). 15 to 
20% of piglets born do not survive to weaning (Quiniou et al., 2002), with low birth 
weight piglets representing 76% of pre-weaning deaths (Ashworth, 2013). In the last 10 
years, pre-weaning mortality has increased with the increase in total numbers of pigs born 
alive (Stalder 2013; 2018; Figures 2.1 and 2.2). This increase in pre-weaning mortality is 
due to an increase in number of low birth weight pigs in each litter.  
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Figure 2.1 Sow farm productivity from 2007 to 2017. Data taken from Stalder (2013, 
2018). 
 
Figure 2.2 Pre-weaning mortality on farms from 2007 to 2017. Data taken from Stalder 
(2013, 2018). 
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birth weights of piglets within a litter (van der Lende and de Jager, 1991). There is a 
negative linear relationship between piglet survival and coefficient of variation for 
within-litter birth weight, and a quadratic relationship between average birth weight and 
mortality of piglets is apparent (Fahmy and Bernard, 1971). Litters containing low-birth-
weight piglets had more piglets born alive and had increased pre-weaning mortality, with 
the majority of deaths being low-birth-weight pigs (Milligan et al., 2002b). Therefore, 
even though these litters were initially larger, they did not produce more weaned piglets 
than litters that were smaller but had no low-birth weight piglets.  
 Intake of colostrum is delayed and inadequate in IUGR or low birth weight piglets 
(Leenhouwers et al., 2002). Low intake of colostrum leads to poor acquisition of passive 
immunity from the dam and poor nutritional status, thereby increasing pre-weaning 
mortality or resulting in poor growth performance during lactation (Yuan et al., 2015). In 
addition, IUGR neonates and low birth weight piglets have a higher susceptibility to 
infection due to an ineffective immune system compared to non-IUGR litter mates 
(Cromi et al., 2009).  
 Internal organs such as the liver and small intestine are smaller in proportion to 
body size in IUGR pigs compared to their larger littermates which leads to a lower 
metabolic capacity (Wu et al., 2006; Yuan et al., 2015). Reduction of metabolic function, 
such as absorptive capacity, due to insufficient growth in utero tends to cause higher 
death losses in these smaller fetuses in utero or of piglets postnatal. Decreased expression 
of proteins which regulate immune function, intermediary metabolism, protein synthesis, 
and tissue growth in the animal may be a major mechanism responsible for abnormal 
absorption and metabolism of nutrients, as well as reduced growth and impaired 
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development of the small intestine, liver, and muscle in IUGR piglets (Wang et al., 
2008).  Inefficient utilization of nutrients has been reported for pigs weighing less than 
1.09 kg at birth (Rezaei et al., 2011), and appears to be caused by physiological 
immaturity at birth due to severe dysfunction of several organs such as the intestine 
(Wang et al., 2013), liver (Lui et al., 2013) and skeletal muscle (Wang et al. 2014). The 
small intestine of IUGR pigs has increased proteins and enzymes associated with 
oxidative stress and protein degradation and decreased abundance of proteins involved in 
maintenance of cell structure, nutrient absorption and transfer, and protein synthesis 
(Wang et al., 2014). Due to increased activity of glutamate oxaloacetate transaminase and 
decreased activity of lipoprotein lipase in the liver of IUGR fetuses, there is an altered 
metabolism of nutrients, abnormal ammonia utilization, and a reduced detoxification 
capacity (Liu et al., 2013). In skeletal muscles of pigs multiple proteins involved in 
energy supply and protein metabolism, structure and type of muscle fibers, proliferation 
and differentiation of muscle fibers, and nutrient transport are differentially expressed in 
IUGR pigs compared to their normal birth weight littermates (Wang et al., 2013). 
Therefore, these overall capacity differences in utilization efficiency of nutrients among 
piglets may partly explain why differences in body weight at birth are often maintained or 
magnified throughout the nursing period (Yuan et al., 2015).  
 Usually, pigs weighing less than 1 kg at birth have very little chance of surviving 
to weaning. However, when these pigs do survive, their post-weaning growth 
performance also is negatively affected (Powell and Aberle, 1980; Quiniou et al., 2002; 
He et al., 2016; He et al., 2018). Higher inefficiency was noted by Quiniou et al. (2002) 
when piglets weighing 0.6 kg at birth required an additional 3 weeks to reach 25 kg 
10 
 
compared to piglets weighing 2.6 kg at birth. Similarly, low birth weight pigs (< 1,000 g) 
grew slower than medium (1,300 to 1,400 g) or high birth weight pigs (> 1,600 g), but 
feed utilization was not significantly affected (Powell and Aberle, 1980). Low birth 
weight pigs required significantly more time (23 days) to reach 106 kg body weight than 
their control littermates (Hegarty and Allen, 1978). In a recent study, slow growing pigs 
were found to have lower concentrations of IGF-1, insulin, leptin, and circulating amino 
acids which is believed to contribute to or be associated with slow growing pigs (He et 
al., 2016). In a separate study, no behavior differences between fast growing and slow 
growing pigs were observed, except that slow growing pigs spent more time at the 
waterers than fast growing pigs (He et al., 2018).  
 Both muscle mass and meat quality at slaughter is impacted negatively in low 
birth weight pigs (Rehfedlt and Kuhn, 2006). The number of secondary and total muscle 
fibers is reduced in IUGR fetuses, which adversely affects growth rate and post-mortem 
quality of meat (Ashworth, 2013; Yuan et al., 2015). Low birth weight pigs were found to 
have significantly larger muscle fiber diameter than larger littermates in the biceps 
brachii, psoas major, and semitendinosus muscles, which can be associated with fewer 
muscle cells (Hegarty and Allen, 1978; Wigmore and Stickland, 1983; Gondret et al., 
2005). The reduction in number of muscle fibers and the larger diameter of those fibers in 
IUGR piglets compared with normal birth weight piglets results in decreased meat 
tenderness and quality of meat and economic losses (Gondret et al., 2005). Low birth 
weight barrows produced fatter carcasses with less lean percentage, while low birth 
weight gilts were similar to large birth weight barrows in carcass composition (Powell 
and Aberle, 1980). Similarly, carcasses from low birth weight pigs (0.80 to 1.20 kg at 
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birth) had the highest amount of intermuscular fat when compared to larger littermates 
(Beaulieu et al., 2010).  
 Genetic selection over time has increased the total number of pigs born per litter, 
which has been accompanied with an increase in pre-weaning mortality. Intrauterine 
growth retardation or an increase in low birth weight pigs, pigs born weighing less than 1 
kg, may be causing the increase in pre-weaning mortality. Intrauterine growth retardation 
will remain a significant problem to the animal industry because there is an incomplete 
knowledge of possible solutions for producers to employ (Wu et al., 2006). Smaller 
piglets that survive past weaning grow slower than their larger litter mates. This reduction 
in growth increases the cost of production for producers or can reduce the amount of 
profit a producer can obtain from these smaller and slower growing pigs. Therefore, 
understanding the mechanisms behind how this phenomenon occurs and potential 
solutions to counteract effects of IUGR is pivotal for swine production today. 
Sow nutrition in gestation   
Nutrition and pregnancy outcomes 
 Due to genetic selection of highly prolific sows, standards set by NRC may or 
may not be the optimal nutritional feeding program during gestation (Campos et al., 
2012). Suboptimal maternal nutrition during gestation leads to insufficient nutrients to 
support metabolic needs of both sows and fetuses. A reason why the swine industry may 
have incorrect nutritional recommendations is that the current dietary guidelines are 
based on genetic lines that are less prolific than sows currently used in commercial 
production (Ball et al., 2008). The modern sow has an increased requirement for energy 
and amino acids that are needed for maintenance but also for reproductive purposes 
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compared to the less prolific sows of the past (Ball et al., 2008). Incorrect maternal 
nutrition along with increased energy and amino acid requirements due to larger number 
of fetuses in the uterus may potentially be associated with the increase in fetal growth 
retardation currently occurring in commercial swine production. When sows enter 
pregnancy, premating maternal undernutrition may negatively affect growth and 
development of early embryos and fetuses (Wu et al., 2006).  
 A reason for high pre-weaning mortality could be that, as the number of fetuses 
increase in utero, the amount of available nutrients per fetus decreases due to a decrease 
in uterine blood flow per fetus (Campos et al., 2012). This is most important in the last 
third of gestation when rapid fetal growth is occurring. Thus, suboptimal maternal 
nutrition during gestation has been regarded as one of the main causes of within-litter 
birth weight variation in modern sow genotypes. An overarching goal of improving 
maternal nutrition is to increase the homogeneity of development of conceptuses to 
decrease variation and improve birth weights of newborn piglets (Yuan et al., 2015). 
 Studies observing effects of maternal nutrition on birth weight have focused on 
different aspects of nutrition. For example, two studies conducted altering energy intake 
of sows (either restricted or above requirements) showed no effect on number of progeny 
alive at birth, mean birth weight of piglets, or piglet weight at weaning (Bee, 2004; 
Lawlor et al., 2007). Contrary to the findings of Bee (2004), other researchers reported 
feeding extra feed or energy in the last 23 days of gestation improved birth weight of 
piglets, but only marginally (Cromwell et al., 1989). Maternal protein intake, when 
deficient, reduces amino acid availability to the conceptus which greatly affects 
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embryonic and fetal survival in pigs (Wu et al., 2010). This topic will be discussed in 
more detail later in this review. 
 Maternal nutrition can affect in utero muscle fiber development in the pig, 
thereby influencing early postnatal growth rate. Prenatal events during fetal development 
affect body composition by influencing formation of secondary muscle fibers (Dwyer et 
al., 1994; Bee, 2004). The difference in carcass lean content between larger and smaller 
littermates may be due to the smaller littermates having lower secondary-to-primary 
muscle fiber ratios (Bee, 2004). These differences in muscle fiber numbers between low 
birth weight piglets and their larger littermates can be a result of maternal undernutrition 
during gestation. Maternal undernutrition is also an important factor that influences fetal 
programming in utero. 
Fetal programming 
 Maternal nutrition and metabolic state have an important impact on embryonic 
and fetal development. There is growing evidence that maternal nutritional status can 
alter the epigenetic state of the fetal genome. Epigenetics is the study of heritable 
phenotypic changes that do not involve alteration in the sequence of DNA. These factors 
(genetics, epigenetics, maternal maturity, environment) affect the size and functional 
capacity of the placenta, uteroplacental transfer of nutrients and oxygen from the mother 
to the fetus, nutrient availability to the conceptus, fetal endocrine milieu, and metabolic 
pathways (Wu et al., 2006).  
 There is extensive evidence for both direct and indirect effects of nutrition on the 
reproductive tract of pigs (Foxcroft et al., 2000). This is also known as fetal 
programming, which occurs during development of the embryo and fetus. During fetal 
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programming, important physiological parameters can be reset by environmental events 
and most importantly these changes can persist into adulthood. This is supported by the 
Barker Hypothesis where events that occur in utero can lead to intrauterine growth 
retardation, low birth weight, and premature birth, and have a causal relationship to the 
origins of hypertension, coronary heart disease and non-insulin dependent diabetes in 
middle aged human adults (Barker and Clark, 1997). However, not all changes due to 
fetal programming are negative. Fetal programming can be beneficial because the 
maternal nutritional state during gestation can prime the fetus for the environment it will 
experience after birth. This process gives the offspring its best chance to survive upon 
birth. Negative influences of fetal programming result when a fetus is subjected to an 
environment that is different than the one it will experience after birth. Understanding the 
mechanisms behind fetal programming is necessary for improving efficiency of pork 
production (Li et al., 2017). 
 Fetal programming can be identified in runt pigs as early as day 27 to 35 of 
gestation (Foxcroft et al., 2014). A considerable proportion of the variation in growth 
performance after birth is determined largely during fetal development in the uterus 
(Foxcroft and Town, 2004). In large litters where uterine crowding occurs, placental 
development can be affected negatively. Dziuk (1968) hypothesized that an inability to 
compensate for the negative effect of fetal crowding on placental development limits fetal 
growth later in gestation. Consequently, placental development of some fetuses may be 
compromised, resulting in IUGR and an increase in birth weight variation as a result of 
crowding in early gestation (Foxcroft et al., 2014). An underdeveloped placenta early in 
gestation due to uterine crowding offers a biological explanation for increased variability 
15 
 
in birth weight and postnatal growth performance observed in older sows where litter 
sizes are larger in earlier parities (Foxcroft et al., 2014). High subsequent feed intakes of 
low birth weight offspring in the growing period does not result in normal development 
during compensatory growth, implying that some form of intrauterine fetal 
reprogramming had occurred (Widdowson, 1976).  
 Maternal nutrition during gestation is very important. Suboptimal nutrition during 
gestation can lead to negative effects in the offspring. Fetal programming is the idea that 
during development of the embryo and fetus important physiological parameters can be 
reset by environmental events which can last into adulthood and be passed onto the next 
generation. However, maternal nutrition and fetal programming are not the only 
determinants of offspring growth. Placental development and function is another 
important factor of growth and development of offspring in utero. 
Placental development and efficiency 
Development  
 Development of the placenta differs among species. Because of these differences, 
placentae are divided into different classifications. Classification of the various types of 
placenta is based on the histologic nature of the maternofetal interface, and represents: 
epitheliochorial (horses and pigs), endotheliochorial (carnivores), synepitheliochorial 
(ruminants), and hemochorial types (primates and rodents). In all placental types 
regardless of species, three fetal layers of the chorioallantoic placenta are present which 
include: the endothelial lining of the allantoic blood vessels, the chorioallantoic 
mesodermal connective tissue, and the chorionic epithelial cell layer also known as the 
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trophoblast layer (Hafez, 2017). The chorioallantoic placenta is the permanent functional 
placenta in domestic mammals, such as mice, pigs, and humans (Hafez, 2017).   
 Implantation begins on day 15 of gestation in pigs (Geisert and Yelich, 1997), and 
the porcine placenta grows rapidly between days 20 to 60 of gestation, with maximal 
development occurring by day 70 (Knight et al., 1977; Wu et al., 2005). This precedes the 
period of rapid fetal growth. The placenta also undergoes rapid formation of new blood 
vessels throughout gestation (Reynolds and Redmer, 2001). However, insufficient 
placental vascularization may lead to progressive deterioration in placental function and 
decreased placental transfer of oxygen and nutrients to fetuses (Wu et al., 2006). 
Maternal undernutrition during gestation may disrupt placental angiogenesis leading to a 
reduction in nutrient transfer between maternal and fetal tissues. Functional capacity of 
placentae for provision of nutrients and the exchange of gases is vital to fetal survival, 
growth, and development (Reynolds et al., 2006).  
 Regulating the synthesis of molecules such as nitric oxide, polyamines, and 
proteins by functional amino acids, such as arginine and glutamine, help stimulate 
placental growth and transfer of nutrients from the dam to the embryos or fetuses, thereby 
promoting conceptus survival, growth, and development (Wu et al., 2006; Wu and 
Meininger, 2009). Functional amino acids are defined as amino acids that participate in 
and regulate key metabolic pathways to improve health, survival, growth, development, 
lactation and reproduction (Wu, 2013). Researchers found that rates of nitric oxide and 
polyamine synthesis, both products of arginine metabolism, in both porcine and ovine 
placentae were greatest during early gestation at the time when placental growth is most 
rapid (Kwon et al., 2004; Wu et al., 2005; Gao et al., 2009). Wu et al. (2004) 
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hypothesized that IUGR results from impaired placental growth, placental vascular 
growth, or placental function caused by a reduction in placental nitric oxide synthesis. 
Therefore, understanding the mechanisms that regulate placental growth, including 
vascular growth and placental function, is crucial for improving litter size and fetal 
growth in pigs (Wu et al., 2010). 
Relationship of placental development to fetal growth 
 Fetal growth depends on placental growth and efficiency which are directly 
related to the placenta’s functional efficiency of delivering nutrients and oxygen to 
fetuses (Salafia et al., 2005, Ashworth, 2013). The establishment of fetal and placental 
circulation is one of the earliest events during embryonic and placental development (Wu 
et al., 2004).  Reynolds and Redmer (2001) evaluated placental angiogenesis and reported 
that the vascular endothelial growth factor, the fibroblast growth factor, and the 
angiopoietin protein families, and their respective receptors, are the major factors 
regulating angiogenesis. Angiogenic factors interact with the local vasodilator, nitric 
oxide, to coordinate placental angiogenesis and blood flow.  Angiogenesis is crucial to 
support the metabolic demands of the fetus, mainly during the latter half of gestation 
when an exponential increase in fetal growth occurs (Reynolds and Redmer, 2001). Also, 
having a better match between uterine capacity and the number of conceptuses in the 
uterus should counteract the detrimental effects on placental development and embryonic 
growth that is measurable by the 28th day of gestation (Foxcroft et al., 2000). 
Placental efficiency 
 Once formed, interfaces between maternal and fetal blood circulations do not 
remain static but change throughout gestation (Georgiades et al., 2002). The fact that 
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placental development is not static is thought to be due to increased placental efficiency 
as gestation progresses. Placental efficiency is the ratio of fetal weight to placental weight 
and is vastly different among species and even breeds within the same species. Placental 
efficiency is determined by placental weight or size, the surface area of contact with the 
maternal endometrium, placental blood flow, and the ability of the placenta to transport 
nutrients to the fetus (Ashworth, 2013). Several other factors, notably the species-specific 
degree of permeability of the various layers making up the maternofetal barrier, the actual 
thickness of these layers, and the spatial relationship between fetal and maternal 
vasculatures, may be more important determinants of the efficiency of transplacental 
exchange of nutrients and waste. Efficiency of nutrient and gas exchange may be 
influenced by the arrangement of the capillary bed between the maternal and fetal 
vasculatures which varies by species. Vallet et al. (2003) suggested that fetal growth rate 
is less sensitive to intrauterine crowding than placental growth rate. In prolific Meishan 
females, an increase in placental efficiency may initially protect the developing fetus 
from a limitation in placental size (Vallet et al., 2003).  
 During late gestation, the placenta increases its performance without a 
proportionate increase in size through increased efficiency (Georgiades et al., 2002).  As 
gestation progresses, intrauterine competition among littermates for the establishment of 
adequate surface area for nutrient exchange between fetal and maternal circulations may 
act to limit total litter weight and increase variation within littermates. Because uterine 
space is a factor limiting fetal growth, establishing a more efficient placenta could 
increase birth weights and reduce weight variation that occurs in utero.  
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 Evidence supporting this enhanced placental efficiency is present in both humans 
and mice where the increase in fetal weight during late gestation is disproportionately 
higher than the minor increase in placental weight (Georgiades et al., 2002). For example 
during the third trimester of human pregnancy, placental weight increases by only 15% 
but fetal weight increases about 200%. This phenomenon is also observed in mice during 
the last quarter of gestation when placental weight remains relatively constant but fetal 
weights increase about 200% (Georgiades et al., 2002). This increase in efficiency results 
from an increase in blood vessels of the human fetal placenta and mouse labyrinth 
consistent with an increased efficiency in physiological exchanges between fetal and 
maternal blood. 
Differences in placental function among swine breeds   
 Placental development differs among swine breeds. Due to increased prolificacy 
of modern sows, fetal growth and development has been limited by decreased uterine 
blood flow to each fetus (Campos et al., 2012). When comparing Yorkshire and Meishan 
uteri with regards to fetal and placental development, an increase in vascular density of 
the placentae was observed in the Meishan while in the Yorkshire only an increase in 
surface area of the placentae was observed (Biensen et al., 1998). Meishan placentae are 
about 70% smaller than the American breed, Yorkshire, but they are more highly 
vascularized (twofold more than Yorkshire) and therefore more efficiently transfer 
nutrients to fetuses even though the placenta is smaller for each fetus (Wilson et al., 
1998). Well-developed placental vasculature enables the Meishan fetus to obtain 
sufficient nutrients from a relatively small placenta (Bazer et al., 1988), resulting in an 
increased rate of prenatal survival (Wu et al., 2010). Size of the fetus and piglet is 
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determined by the size and vascularity of its placenta (Wilson et al., 1998). Placental 
weight and surface area are reduced by 40% in Meishan placentae, compared with 
Yorkshire (Biensen et al., 1999). Markedly larger placentae (weight and surface area) 
were recovered from Yorkshire than from Meishan uteri on days 90 to 110 of gestation. 
Fetal weight increased from days 90 to 110 of gestation, however placental weight 
remained constant in the Meishan. This led to an increase in placental efficiency of the 
Meishan from 2.9 to 4.8, respectively (Biensen et al., 1999). 
 The same group at Iowa State University used embryo transfer to allow Yorkshire 
and Meishan females to have both Yorkshire and Meishan conceptuses brought to term. 
This study was conducted to observe differences in placental development between the 
two breeds when the dam is not of the same breed as the conceptus. Placental surface 
area remained relatively constant during the last third of gestation for Meishan 
conceptuses regardless of breed in which the fetuses were gestated (Biensen et al., 1998). 
Regardless of sow breed, the vascular density of Meishan placentae increased 
progressively from 3.0% on day 70 to 6.0% on day 110 of gestation, reaching values 
more than twofold greater than the vascular density observed in Yorkshire placentae on 
day 110 (2.8%; Biensen et al., 1998). This increase in vascular density of Meishan 
placentae was through both increases in diameter and number of blood vesels in the 
plcenta. Placental efficiency on day 110 of gestation was evaluated between breeds by 
taking the weight of each fetus and dividing it by its placental weight. The Meishan 
conceptuses demonstrated a greater fetal weight:placental weight ratio across both uterine 
environments over Yorkshire conceptuses. When Meishan conceptuses were gestated in a 
Meishan uterus, placental efficiency was markedly greater than when gestated in a 
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Yorkshire uterus. The size of the placenta is driven by the uterus in which it is gestated 
up to day 90 of gestation. After day 90, when rapid fetal growth occurs, the genetic 
differences between breeds start to play a role. At this time, an increase in placental size 
is observed in Yorkshire conceptuses and an increase in vascularity is seen in Meishan 
conceptuses in order to facilitate the increased nutrient and waste exchange that occurs 
after day 90 of gestation.  
 Development of the placenta is an important step in gestation. Different molecules 
such as nitric oxide and polyamines stimulate placental growth and development. A well-
developed placenta helps ensure healthy growth and development of the fetus. The 
placenta constantly undergoes angiogenesis allowing for nutrient transfer to occur 
between maternal and fetal blood vessels. The efficiency of the placenta can differ. Some 
placentae such as for Yorkshire pigs tend to increase in size throughout gestation keeping 
the vasculature the same diversity whereas the placentae for Meishan pigs tend to be 
smaller and increase in vascularity throughout gestation. 
Previous intervention studies to mitigate incidence of low birth weight pigs 
Hormones 
 Possible interventions to improve placental and fetal development previously 
researched include administration of exogenous hormones. When administering porcine 
growth hormone (GH) to sows, an increase in fetal weight and placental weight was 
observed (Sterle et al., 1995). Others suggest that GH plays a critical role in early 
gestation by positively influencing nutrient transfer, placental growth, and selectively 
improving growth conditions for smaller piglets (Rehfeldt et al., 2001). Studies have 
indicated that a greater physiological maturity at birth (i.e. body and tissue composition 
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and metabolic and hormonal state) also increase the likelihood of piglet survival 
(Leenhouwers et al., 2002).  
Bump feeding 
 One strategy to improve piglet birth weight is to increase feeding levels to sows 
during late gestation. This is often referred to as “bump feeding”. Numerous studies have 
been conducted to evaluate this practice. This strategy is used in both sows and gilts. In 
sows, increasing the feeding level has not shown any significant improvement in birth 
weights of the litters (Cromwell et al., 1989; Miller at al., 2000; Shelton et al., 2009; 
Gonçalves et al., 2016; Mallmann et al., 2018). Though the general consensus is that 
bump feeding in sows does not affect birth weight, many of these studies have only been 
conducted through one reproductive cycle. Cromwell et al. (1989) showed an increase in 
birth weight when increasing feed during late gestation over multiple cycles. This 
observation may be explained by the sow having time to increase their body nutrient 
stores. In contrast, gilts respond to elevated feeding levels differently than sows. In 
general, elevating the feed intake in late gestation for gilts improved litter birth weights in 
several studies (Cromwell et al., 1989; Shelton et al., 2009; Gonçalves et al., 2016), but 
not all studies (Mallmann et al., 2018). A potential reason for the increase in birth weight 
in gilts and not in sows could be due to the fact that gilts are still growing and 
developing. Nutrients and energy that a gilt consumes need to first cover body 
maintenance requirements and growth before being put towards fetal growth. By adding 
extra nutrients or energy, gilts can partition more nutrients toward fetal development. 
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Amino acids 
 Another approach to mitigate IUGR or low birth weights is to enhance placental 
function. This may be achieved by supplementing sows during gestation with the 
functional amino acid, arginine. There is strong evidence that members of the arginine 
family of amino acids (arginine, glutamine, glutamate, proline, aspartate, asparagine, 
ornithine, and citrulline) have an important role in placental vascularization and 
development, especially during the first half of pregnancy (Campos et al., 2012). All of 
these amino acids have an important role in placental angiogenesis and placental, 
embryonic, and fetal development. According to Wu et al. (2010), nitric oxide, 
polyamines, arginine, and other functional amino acids (glutamine, leucine, proline) may 
regulate embryonic and fetal muscle growth and development via cell signaling through 
the mammalian target of rapamycin (mTOR) pathway. Sows supplemented with arginine 
had heavier placentae (Gao et al., 2012), and a greater litter birth weight of all piglets 
born and of all piglets born alive (Li et al., 2015) compared to sows without 
supplementation. Dietary supplementation with 0.83% L-arginine to gilts on days 14 to 
28 or days 30 to 114 of gestation increased the number of live-born piglets and litter birth 
weight of live-born piglets (Ramaekers et al., 2006). In addition, supplementing the 
gestation diet with 0.4% L-arginine plus L-glutamine enhanced efficiency of dietary 
protein utilization by the sow, reduced variation in piglet birth weight, and increased litter 
birth weight (Wu et al., 2010). Therefore, increasing the dietary provision of arginine 
beyond that from a typical corn-soybean meal diet may be an effective means to enhance 
circulating arginine concentrations and improve pregnancy outcomes in pigs (Wu et al., 
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2007). Similar results were observed when rats were supplemented with arginine during 
early or mid-gestation (Zeng et al., 2008).  
 Researchers have investigated different types of interventions to reduce the 
incidence of IUGR and low birth weight pigs. Exogenous growth hormone reduced 
incidence of low birth weight pigs but it is not approved for the use in swine by U.S. 
FDA. If an intervention can be identified that naturally increases endogenous growth 
hormone production, it may be promising. Bump feeding has been studied but has 
yielded inconclusive results regarding effects on birth weight where it is not shown to be 
effective in sows and may be effective in gilts. Supplementing diets with arginine 
increased birth weight but few trials have been conducted to evaluate effects on 
variability of birth weight. 
β-hydroxy-β-methylbutyrate 
Introduction to leucine and β-hydroxy-β-methylbutyrate 
 Amino acids are essential to biosynthesis of proteins. Some amino acids can be 
produced endogenously by the animal and others must be supplied through the diet. 
Amino acids that must be supplied in the diet are known as essential amino acids. 
Leucine, an essential amino acid in swine diets, plays a role in protein synthesis. In both 
in vitro and in vivo studies with rats, leucine has a direct effect on stimulating muscle 
synthesis (Anthony et al., 2002; Bolster et al., 2004) and inhibiting protein breakdown in 
muscle in vitro (Buse and Reid, 1975). β-hydroxy-β-methylbutyrate (HMB), a leucine 
metabolite, also plays a role in skeletal muscle development and reduction of proteolysis 
(Nissen and Abumrad, 1997; Slater and Jenkins, 2000; Wheatley et al., 2014). β-hydroxy-
β-methylbutyrate is produced from α-ketoisocaproate (KIC), another metabolite of 
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leucine, via KIC dioxygenase enzyme (Nissen and Abumrad, 1997; Slater and Jenkins, 
2000; Baxter et al., 2005). Approximately 2 to 10% of leucine oxidation proceeds to 
synthesis of HMB (Slater and Jenkins, 2000). In vitro data are consistent with the theory 
that HMB is responsible for the non-protein synthetic functions of leucine and KIC in 
vivo (Nissen and Abumrad, 1997).  
 In addition to its role in muscle synthesis, β-hydroxy-β-methylbutyrate can be 
converted to β-hydroxy-β-methylglutaryl coenzyme A (HMG-CoA) in some tissues and 
acts as the key carbon source for de novo cholesterol synthesis necessary for maintenance 
of maximal cell function (Nissen and Abumrad, 1997; Baxter et al., 2005). Cholesterol is 
also a precursor for many glucocorticoids, such as cortisol. β-hydroxy-β-methylbutyrate 
cannot fulfill the leucine requirement for protein synthesis.   
 β-hydroxy-β-methylbutyrate is used by humans but few studies have been 
conducted in animals to determine product safety.  A toxicology study was conducted 
with 20-kg pigs fed 100 g HMB per day for 4 days (Nissen and Abumrad, 1997). This 
dose is approximately 100X higher than what is typically consumed by adult humans. 
None of the pigs exhibited untoward signs related to HMB consumption. There were no 
changes in blood cell parameters or percentages, organ weights, nor were there any 
histological lesions present in either control or HMB-fed pigs. Therefore, it seems that 
even at very high intakes there are no adverse effects, at least for a short amount of time. 
Another toxicology study was conducted to evaluate the toxicity of the calcium salt of 
HMB (CaHMB) when administered daily in the diet of rats for at least 90 days (Baxter et 
al., 2005). Administration of CaHMB in a basal diet for 91 days was tolerated well 
having no unscheduled sacrifices or deaths and no adverse effects on body weight gain. 
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Therefore, Baxter et al. (2005) concluded the no-observed-adverse-effect level for 
CaHMB was 5% of the daily diet under these experimental conditions. Also in a 
summary of nine clinical studies in humans, HMB had no adverse effects when 
supplemented at 3 g/d in men, women, young, and elderly subjects (Baxter et al., 2005). 
Mode of action of leucine and HMB 
 Leucine and HMB may work through several proposed mechanisms. Increases in 
lean mass elicited by both leucine and HMB are thought to involve both decreases in 
muscle protein breakdown (Baxter et al., 2005) and increases in muscle protein synthesis 
simultaneously (Wheatley et al., 2014).  
Leucine 
 Previous work utilizing the neonatal pig shows protein synthesis is acutely 
increased in neonates in response to supplementation of the branched chain amino acid, 
leucine (Wheatley et al., 2014). Leucine serves as a substrate for protein synthesis and as 
a nutrient signaling molecule that stimulates protein synthesis through activation of the 
intracellular signal transduction pathway that regulates mRNA translation (Wheatley et 
al., 2014).  
 In vitro observations clearly demonstrate that muscle protein turnover in rats and 
chicks is affected significantly by increasing protein synthesis with leucine and HMB at 
pharmacological levels exceeding 5 to 200 fold physiological concentrations (Ostazewski 
et al., 2000). Leucine was proved to significantly increase protein synthesis; however, it 
did not significantly inhibit proteolysis. The conclusion from this study is that leucine 
increases protein synthesis and HMB, but not leucine, significantly inhibited proteolysis 
(Ostazewski et al., 2000). 
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β-hydroxy-β-methylbutyrate 
 Based on many studies, researchers postulated that HMB supplementation would 
involve the following mechanisms: (1) upregulation of IGF-1 gene expression in skeletal 
muscles, (2) stimulation of protein synthesis by increasing the mTOR signaling pathway, 
and (3) suppression of proteolysis by the inhibition of the ubiquitin-proteasome system 
(Zanchi et al., 2011). β-hydroxy-β-methylbutyrate is claimed to increase strength and 
lean body mass by acting as an anti-catabolic agent, and minimizing protein breakdown 
and damage to cells that may occur with intense exercise (Slater and Jenkins, 2000). 
While it would appear that in vivo observations of HMB are clear in humans undergoing 
resistance-weight training (Ostazewski et al., 2000), further studies need to be conducted 
to determine what effect HMB might have on protein degradation in either normal or 
extremely catabolic humans as well as its effects on animals.  
 β-hydroxy-β-methylbutyrate effects on hormones (GH, IGF-1). 
 A few studies have been conducted to observe the effects of HMB on growth 
hormone (GH) and insulin-like growth factor 1 (IGF-1). Supplementation of HMB to 
sows increased GH and IGF-1 in the serum of offspring (Tatara et al., 2007; Tatara et al., 
2012). Similarly, supplementing HMB to lambs during the first 21 days of life increased 
serum concentrations of GH and IGF-1 (Tatara, 2008). Data point out a stimulatory effect 
of HMB on the production of hepatic IGF-1 (Zanchi et al., 2011). IGF-1 is produced by 
both the liver and muscle in response to treatment with HMB and could act on skeletal 
muscle in an endocrine, paracrine, and autocrine fashion (Zanchi et al., 2011). IGF-1 
exerts an anabolic action in skeletal muscle leading to hypertrophy of muscle fibers 
(Barton-Davis et al., 1998; Fiorotto et al., 2003). Chronic HMB treatment of rats 
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increased serum somatotrophic hormones as well as increased levels of pituitary GH 
mRNA and hepatic IGF-1 mRNA (Gerlinger-Romero et al., 2011). In human myoblasts, 
HMB increased IGF-1 mRNA expression (Kornasio et al., 2009). Bondine et al (2001) 
demonstrated that hypertrophy of myotubes in vitro induced by IGF-1 was dependent on 
the pathway initiated by PI3K and Akt, which leads to the activation of mTOR. IGF-1 
promotes activation of protein synthesis by stimulating the process of initiation of mRNA 
translation. Further studies are needed to understand and determine if activation of this 
signaling pathway by HMB occurs as a result of increased expression of IGF-1. 
β-hydroxy-β-methylbutyrate effects on the mTOR pathway   
 The enzyme known as mTOR is a protein kinase responsive to mechanical, 
hormonal, and nutritional stimuli and plays a central role in controlling cell growth, 
primarily by controlling mRNA translation efficiency. β-hydroxy-β-methylbutyrate acts 
upon the mTOR pathway by yet unknown mechanisms, increasing the phosphorylation of 
its protein substrates (4EBP-1 and p70S6K) and resulting in increased myofibrillar 
protein synthesis (Zanchi et al., 2011).  β-hydroxy-β-methylbutyrate alone augments 
skeletal muscle protein synthesis in swine neonates in association with the activation of 
mTOR signaling (Wheatley et al., 2014). Increased protein synthesis in skeletal muscle 
occurs because of activation of the mTOR-dependent translation initiation factors 
(Wheatley et al., 2014). Overall, Wheatley et al. (2014) reported an increase in protein 
synthesis when supplementing HMB to swine neonates due to an increase in activation of 
the mTOR pathway with no differences in proteolysis. 
  In a cell culture model, incubation with 50 mM of HMB significantly stimulated 
muscle protein synthesis. This response was correlated positively with an increase in 
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phosphorylation of mTOR and two important substrates of mTOR (4EBP-1 and 
p70S6K), which are proteins involved in increased translation of mRNA and protein 
synthesis in muscle (Eley et al., 2007). Importantly, this stimulating effect was 
completely abolished in the presence of rapamycin, an mTOR inhibitor. Eley et al. (2008) 
found that HMB could attenuate the depression of protein synthesis by modulating 
protein synthesis inhibitors such as: lipopolysaccharides, tumor necrosis factor alpha, and 
angiotensin 2. 
 Expression of mTOR and other proteins involved in insulin signaling were 
investigated to better understand HMB-stimulated skeletal muscle hypertrophy (Pimental 
et al., 2011). In a one-month period, HMB treatment at 320 mg/kg BW induced a 
significant increase in weight of the extensor digitorum longus muscle and soleus 
muscles but did not change total body weight, food intake, or fat and liver weight in rats 
3 to 4 months of age. Relative to the control group, the supplemented group demonstrated 
an increase in mTOR protein levels and activation of p70S6K, which are linked to 
increased skeletal muscle mass in the extensor digitorum longus muscle (Pimental et al., 
2011). Supplementation of HMB increased skeletal muscle protein mass by directly 
inducing increased mTOR expression and activation of p70S6K and not via 
phosphorylation of Akt/PKB. Based on the results from this study, the mechanism of 
action for HMB appears to be related to increases in mTOR/p70S6K pathway signaling 
which leads to improved protein synthesis and muscle hypertrophy (Pimental et al., 
2011).   
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β-hydroxy-β-methylbutyrate effects on the ubiquitin-proteasome system  
 The ubiquitin-proteasome system is a proteolytic system dependent on energy 
(ATP) and degradation of intracellular proteins whose activity is increased in conditions 
of exacerbated muscle catabolism, such as fasting, hypogravity, immobilization, and bed 
rest (Lecker et al., 2006). Smith et al. (2005) observed in mice implanted with MAC16 
tumor cells that HMB supplementation was effective in reducing muscle proteolysis 
observed in cancer-induced cachexia, which was reflected in the attenuation of muscle 
mass loss. Importantly, this observation was correlated positively with a decrease in 
catalytic activity of the proteasome. Supplemental HMB can markedly decrease muscle 
damage as evidenced by reduced leaking of creatine phosphokinase (CK) out of muscle 
cells during strenuous exercise. Oral supplementation of HMB can slow or partially 
prevent muscle wasting by suppressing upregulation of the ubiquitin-proteasome system 
and by enhancing protein synthesis rates (Smith et al., 2005).   
 There are a few potential mechanisms in which HMB can act in the body. β-
hydroxy-β-methylbutyrate has been connected to both increasing protein synthesis and 
decreasing proteolysis, increasing serum growth hormone and insulin-like growth factor 
1 concentrations as well as mRNA expression for growth hormone and insulin-like 
growth factors 1, activation of the mTOR pathway and inhibition of the ubiquitin-
proteosome system. Potential mechanisms of action presented suggest that HMB 
supplementation could influence animal production positively. 
Effects of excess dietary leucine 
 Researchers have found that feeding the branched chain amino acid (BCAA) 
leucine in excess can have negative effects on animals. Although the branched chain 
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amino acids (leucine, isoleucine, and valine) are essential amino acids they are also toxic 
at high concentrations (Harris et al., 2004). The majority of research has been conducted 
on leucine. Some negative effects of excess dietary leucine can reduce levels of some 
amino acids in the circulating amino acid pool and reduce growth performance in 
animals.  
 All branched chain amino acids share the same regulatory enzyme in their 
catabolic pathway, α-ketoacid dehydrogenase complex (BCKDC). Activity of this 
enzyme is under tight control for both conserving and oxidizing all BCAAs (Harris et al., 
2004). This is important because a lack of BCKDC activation could lead to an excess of 
BCAA in the blood leading to neurological dysfunction and brain damage (Harris et al., 
2004). 
 High intakes of leucine in both humans and animals has been shown to decrease 
the concentrations of the other branch chain amino acids in both blood and muscle 
(Harper et al., 1984; Wiltafsky et al., 2010). This is believed to be due to the increase in 
activity of BCKDC from increased leucine. Excess leucine intake increases the activity of 
the shared enzyme which depletes the plasma and tissue stores of isoleucine and valine as 
well as their keto-acids (Harper et al., 1984). Similar observations were found when 
feeding excess leucine to weaned pigs where the increased intake of leucine increased 
plasma leucine and its keto-acid while decreasing plasma levels of isoleucine and valine 
and their keto-acids (Wiltafsky et al., 2010). However, branched chain amino acids are 
not the only amino acids in plasma influenced by extensive leucine. Plasma levels of 
histidine, threonine, and serine increased linearly; methionine and proline were 
influenced quadratically; and aspartic acid and glutamine decreased linearly with 
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increasing levels of leucine in the diet over 100% of requirement. This experiment also 
showed a reduction in growth performance in the animals when fed excess leucine. In 
two separate experiments increasing leucine concentrations over what they marked as 
100% in the diet linearly decreased daily feed intake and gain (Wiltafsky et al., 2010). 
 Depressed feed intake in pigs fed excess dietary leucine has been shown in 
multiple studies (Wiltafsky et al., 2010; Wessels et al., 2016a; Wessels et al., 2016b). 
Reduction in food intake caused by excess leucine intake is thought to be due to a 
decrease in hypothalamic serotonin concentration in animals fed high leucine. Plasma 
leucine was negatively correlated with hypothalamic tryptophan, which is used in 
serotonin production (Wessels et al., 2016a; Wessels et al., 2016b).  
 Caution must be taken when supplementing leucine to humans or animals due to 
the negatives effects of excess leucine discussed above. Since HMB and leucine act in 
similar ways, it is plausible that HMB can be used instead of leucine leaving behind the 
negative effects that leucine has on the body’s amino acid pool and growth performance. 
At this point in time, it is unknown if high levels HMB has any effects, positive or 
negative, on the concentrations of plasma branched-chain amino acids. 
Previous animal studies supplementing HMB 
Swine  
 Maternal supplementation of HMB before and throughout lactation has yielded 
mixed results. For example, Nissen and coworkers (1994) found that HMB supplemented 
sows had elevated fat content in the colostrum whereas Flummer and Theil (2012) did not 
observe any changes in composition of colostrum but did report an increase in yield of 
colostrum. Pre-weaning mortality was lower in piglets from sows supplemented with 
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HMB (Flummer and Theil, 2012). This could potentially be due to the increase in 
colostrum production allowing all piglets to have a sufficient amount and gain the 
necessary nutrients and passive immunity from the sows. Over three trials, consistently 
improved pig weight gains were observed from HMB-fed sows. Feeding 2.0 g HMB/day 
starting 2 days before parturition through lactation increased weaning weight at day 21 by 
7% (Nissen et al., 1994). HMB supplementation to sow diets throughout lactation 
increased concentration of HMB in milk and skeletal muscle of pigs 28 days after birth 
(Wan et al., 2017). 
 Maternal HMB supplementation provides benefits to growth performance of 
offspring in both pigs and sheep (Tatara et al., 2007). Piglets born from sows 
supplemented with HMB were significantly heavier at birth and expressed increased 
daily weight gain allowing them to reach market weight faster than pigs born to un-
supplemented sows (Tatara et al., 2007). Offspring from sows supplemented with HMB 
had a greater body weight and lean percentage at market than did pigs from sows that 
were not supplemented (Wan et al., 2017). Tatara and others (2012) conducted another 
study following offspring to market after maternal supplementation during the last two 
weeks of gestation and supplementation of HMB to offspring pre- and post-weaning. 
Treatment with HMB reduced fattening time and increased body weight at birth, daily 
body weight gain, bone weight, volumetric bone mineral density, and geometrical 
parameters and mechanical endurance of the femur of the offspring (Tatara et al., 2012).  
 Supplemental HMB also enhances protein synthesis in skeletal muscle of swine 
neonates. Fetuses were programmed prenatally due to maternal supplementation of HMB 
in late gestation and had increased liver size (and probably metabolic capacity), improved 
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immune function, and increased lean tissue gain over pigs whose dams were not 
supplemented (Flummer et al., 2012). Intrauterine growth retarded piglets fed HMB at 
800 mg/kg during days 7 to 28 after birth had a net body weight gain and average daily 
gain similar to that of normal birth weight piglets fed a control diet (Wan et al., 2016a). 
Not related to body weight, HMB supplementation markedly increased the cross-
sectional area of type II muscle fibers and the mRNA expression of mTOR, IGF-1, and 
myosin heavy chain isoform IIB in the longissimus dorsi muscle of piglets (Wan et al., 
2016a). These findings demonstrate that HMB supplementation during the early postnatal 
period could improve skeletal muscle growth and maturity by accelerating fast-twitch 
glycolytic fiber development in pigs.  
Poultry 
 β-hydroxy-β-methylbutyrate has also been studied in poultry. A study was 
conducted using Arbor Acres broilers with three dietary treatments supplemented with 
HMB-Ca (0, 0.05%, 0.1%) during the starter (1-21 days) and grower (22-42 days) phases. 
At day 21, birds receiving 0.1% HMB-Ca had more breast muscle yield, less abdominal 
fat than the control, and a higher dressing percentage than birds fed the control or 0.05% 
HMB-Ca (Qiao et al., 2013). At day 42 of age, 0.1% HMB-Ca increased breast muscle 
yield than the control and decreased abdominal fat compared with the control or 0.05% 
HMB groups (Qiao et al., 2013). Overall dietary treatment of HMB-Ca did not affect 
serum growth hormone or insulin in any of the treatments. This study suggests that 
dietary supplementation of HMB-Ca improved growth performance, stimulated breast 
muscle development, and decreased abdominal fat deposition in broiler chickens.  
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Ruminants 
  Steers supplemented with HMB beginning 82 days before market expressed 
improved daily weight gain, feed intake, and feed efficiency when slaughtered at 105 
days on feed (Van Koevering et al., 1994). However, a second group marketed at 147 
days had an overall poorer performance than the earlier marketed group. The reason 
behind this reduction was that this group had a lower overall performance prior to 
supplementing HMB (Van Koevering et al., 1994). The steers from the HMB group in 
this study also had leaner carcasses than the un-supplemented steers (Van Koevering et 
al., 1994).  
 In animal production, HMB has potential to be a promising tool. β-hydroxy-β-
methylbutyrate can increase birth weights and market weight in swine. β-hydroxy-β-
methylbutyrate has also been shown to produce leaner carcasses in both swine and 
ruminants. More research is needed to fully understand all the effects that HMB may 
have when supplemented to animals and determine a range of doses that are most 
effective in each species.   
Mouse model for study of litter bearing species 
 Sow studies can be a challenge to conduct due to their long gestation length, large 
space requirements, and high expense. Utilizing another litter bearing species as a model 
for sows could be beneficial. Mice are a litter bearing species that also exhibit 
intrauterine growth retardation. A colony of genetically identical mice housed in a 
controlled environment on the University of Minnesota’s St. Paul Campus have a within-
litter birth weight coefficient of variation of 10% (Clarke et al., unpublished). This is only 
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slightly lower than the 15% to 25% that has been reported in sows (Wu et al., 2010; 
Quesnel et al., 2014). 
Lifespan and housing 
 The most common mouse used in a research setting is the C57Bl/6j strain also 
known as Black 6. These mice have an average lifespan of two years. The average mature 
body size for this strain is around 25 grams (Bachmanov et al., 2002). On average, adult 
mice can drink up to 5 ml of water per day and eat between 4 and 5 grams of chow per 
day. Feed intake increases depending on the physiological state of the animal and ranges 
from 5 grams per day, for maintenance, to up to 20 grams per day during lactation 
(Speakman, 2008). 
 Mice are social animals, so they are typically housed in groups but can be housed 
individually under special circumstances. Under group housing situations in a standard 
size cage, females of the same litter are housed in the same cage with up to 5 adult mice 
per cage. Males from the same litter are housed together with up to 4 adults per cage. 
Males housed with non-littermate males will fight so this is avoided by housing one litter 
of males per cage.  
Reproduction 
 Mice reach sexual maturity between 4 and 6 weeks of age. However, typical 
breeding age is 6 to 8 and 8 to 10 weeks of age for females and males, respectively. 
Breeding exhaustion for mice is typically 5 to 6 litters over a span of 8 to 12 months. 
Mice can be mated individually (one male and female per cage), in trios (one male with 
two females) or as a harem (one male with three or more females). Timed mating can be 
accomplished by observing presence of a copulatory plug, but usually pregnancy can be 
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visually determined by abdominal distension by 12 to 14 days into gestation and by a 
noticeable increase in dam body weight. 
 The average gestation length for a mouse ranges between 18 and 22 days. Mice of 
the C57/Bl6 strain have an average gestation length of approximately 19.2 days (Murray 
et al., 2010). Litter sizes in the mouse are 4 to 12 pups with an average of 6 pups per 
litter. Lactation for a mouse can last for 4 weeks. Normally, mouse pups are weaned from 
the dam at 21 days of age but can be weaned at 28 days of age if the pups are deemed too 
small to survive on their own at 21 days of age. Average weaning weight for Black 6 
mice is approximately 9 grams for both males and females. Mice weighing under 7 grams 
at weaning are less likely to survive than if they weighed over 7 grams. These small pups 
are weaned at 28 days to increase their body weight (personal observations). 
Comparison of placental development between mice and swine 
Mouse 
 The first part of placental development after fertilization is decidualization 
(Malassiné et al., 2003). In the mouse, this process is induced by implantation. An 
interesting fact about the mouse placenta is that it is actually not fully formed until 
halfway through gestation. The mouse placenta initially possesses a choriviteline 
structure but changes into a chorioallantoic structure at 11.5 days of gestation (Malassiné 
et al., 2003). By 12.5 days of gestation, the definitive chorioallantoic placenta is clearly 
subdivided into: i) layer of maternal decidua, ii) junctional zone, and iii) labyrinth zone, 
which can be seen below in Figure 2.3. 
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Figure 2.3. Histological section of mouse placenta documenting the three main 
layers.Photo credit Clarke, 2019. 
 The mouse labyrinth structure allows countercurrent exchanges between maternal 
and fetal capillaries arranged in parallel to each other (Malassiné et al., 2003). In the 
labyrinth, the trophoblast begins to differentiate into three layers; 2 syncytiotrophoblast 
layers in contact with the fetal endothelium, and only one cytotrophoblast in contact with 
maternal blood. The maternal blood then enters the labyrinth and bathes the fetal 
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trophoblast, allowing exchanges with fetal blood. A labyrinth placenta is the most 
structurally elaborate type and is found in rodents. In these species, the chorion is 
penetrated by a web-like arrangement of channels (Hafez, 2017). 
Swine 
 The placental type of swine is diffuse. A diffuse placenta is when maternal and 
fetal tissues interdigitate over the entire surface of contact. This is also known as a folded 
type placenta which is the simplest form that describes the geometrical pattern of the 
maternal and fetal tissues (Hafez, 2017). Another type of classification of the porcine 
placenta is epitheliochorial. The epitheliochorial type is the most superficial placenta, 
lacking significant invasion of the uterine tissues. Pigs possess a variant form of placental 
circulatory system termed a crosscurrent system (Figure 2.4). The crosscurrent system is 
an intermediate with respect to the efficiency of exchange of nutrients and gases between 
an exclusively concurrent (not documented in any mammal to date) and exclusively 
countercurrent arrangement (guinea pig). Concurrent systems are the least efficient for 
nutrient transfer and countercurrent systems are the most efficient and ideal for nutrient 
transfer (Ahokas and McKinney, 2008). 
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Figure 2.4. Nutrient exchange flow in swine placenta, Crosscurrent system. Diagram 
adapted from Leiser R. and P. Kaufmann, 1994. 
 Sow studies can be difficult to perform for multiple reasons leading to the benefit 
of finding a cost-effective model for the sow. Mice are litter bearing species that are also 
affected by intrauterine growth retardation and varying birth weights. The gestation 
length of a mouse is much shorter at 19-21 days compared to approximately 115 days for 
the sow. Other benefits of mice are that they can be housed in a relatively small space, 
are inexpensive, and have the same issue of variation in birth weights even when 
genetically identical and housed in a controlled environment. When using the mouse as a 
model for the pig some precautions need to be taken when considering dosing between 
the two species. To ensure correct dosing, allometric scaling of the doses should be 
performed.  
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Allometric scaling 
 Allometry is the study of size and its consequences. The scaling of biologically 
functional systems can be studied and described mathematically by using allometric 
equations (Sharma and McNeill, 2009). Allometric scaling is a tool used to extrapolate 
doses of medication or nutritional supplements among species. Obviously, an elephant is 
not the same size as a mouse and therefore they need different doses of a drug to elicit the 
same effects. To understand allometry, it helps to understand the relationship between the 
metabolic rate of an animal and its size. This relationship is known as Kleiber’s Law. 
Kleiber’s Law was developed in 1932 and states that the metabolic rate for all organisms 
follows exactly the ¾ power-law of body mass. Although the ¾-power law is valid, as 
research continues to be conducted and technology improves, researchers are finding that 
this idea is not exactly as straight forward as it appeared when first discovered in the 
1930’s (Glazier, 2005). 
 There are multiple ways, other than using metabolic body size, that dosing using 
scaling can be determined and there is much debate about which method is best. For drug 
dosing there is the “dose by factor” method which applies an exponent for body surface 
area (Equation 1). 
Equation 1: 
HED* (mg/kg) = Animal NOAELǂ (mg/kg) x (weightanimal [kg] / weighthuman [kg])1-0.67# 
*Human equivalent dose 
ǂNo observed adverse effect level 
#Range of superscripts that can be used for this equation  
Equation taken from Nair and Jacob (2016) 
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 Equation 1 above is based on body weight of the test animals and humans. Basing 
doses directly by body weight however has resulted in gross over or underestimations of 
doses. For example, the direct extrapolation of a dose established in mice or rats to an 
adult human may actually be wrong by a factor of 10 or more (Rucker and Storms, 2002). 
To address this inaccuracy, correction factors (Km) were calculated and equation 1 was 
updated to equation 2 with Km factors located in Tables 2.1 and 2.2. 
Equation 2: 
HED (mg/kg) = Animal NOAEL (mg/kg) x (animal Km / human Km) 
Equation taken from Nair and Jacob (2016). 
 A third equation (Equation 3) can be used to calculate the animal equivalent dose 
(AED) from human doses. This equation uses a Km ratio which is the human Km divided 
by the animal Km and vice versa. Values of the Km ratios are also denoted in Tables 2.1 
and 2.2.  
Equation 3: 
AED* (mg/kg) = Human dose (mg/kg) x Km ratio 
*Animal Equivalent Dose 
Equation taken from Nair and Jacob (2016). 
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Table 2.1.  Human equivalent dose (HED) calculation based on body surface area. 
Species Reference 
body 
weight, kg 
Working 
weight 
range, kg 
Body 
surface 
area, m2 
Km value
1  Km Ratio
2  Km Ratio
3 
Human 60 - 1.62 37 - - 
Mouse 0.02 0.011-
0.034 
0.007 3 12.3 0.081 
Hamster 0.08 0.047-
0.157 
0.016 5 7.4 0.135 
Rat 0.15 0.08-0.27 0.025 6 6.2 0.162 
Ferret 0.30 0.16-0.54 0.043 7 5.3 0.189 
Guinea 
pig 
0.40 0.208-
0.700 
0.05 8 4.6 0.216 
Rabbit 1.8 0.90-3.0 0.15 12 3.1 0.324 
Dog 10 5-17 0.50 20 1.8 0.541 
Monkey 3 1.4-4.9 0.25 12 3.1 0.324 
Marmoset 0.35 0.14-0.72 0.06 6 6.2 0.162 
Squirrel 
monkey 
0.60 0.29-0.97 0.09 7 5.3 0.189 
Baboon 12 7-23 0.60 20 1.8 0.541 
Micro pig 20 10-33 0.74 27 1.4 0.730 
Mini pig 40 25-64 1.14 35 1.1 0.946 
Table adapted from Nair and Jacob (2016) 
1 Convert dose in mg/kg to dose in mg/m2, multiply by Km 
2 Convert animal dose in mg/kg to HED in mg/kg by dividing animal dose by Km ratio 
3 Convert animal dose in mg/kg to HED in mg/kg by multiplying animal dose by Km 
ratio  
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Table 2.2. Animal equivalent dose (AED) calculation based on body surface area.  
Species Reference body 
weight, kg 
Km Value
1 Km Ratio
2  Km Ratio
3  
Human 60 37 - - 
Mouse 0.02 3 12.3 0.081 
Hamster 0.08 5 7.4 0.135 
Rat 0.15 6 6.2 0.162 
Ferret 0.30 7 5.3 0.189 
Guinea pig 0.40 8 4.6 0.216 
Rabbit 1.8 12 3.1 0.324 
Dog 10 20 1.8 0.541 
Monkey 3 12 3.1 0.324 
Marmoset 0.35 6 6.2 0.162 
Squirrel 
monkey 
0.60 7 5.3 0.189 
Baboon 12 20 1.8 0.541 
Micro pig 12 27 1.4 0.730 
Mini pig 40 35 1.1 0.946 
Table adapted from Nair and Jacob (2016)  
1 Convert dose in mg/kg to dose in mg/m2, multiply by Km 
2 Convert human dose in mg/kg to AED in mg/kg by multiplying animal dose by Km 
ratio 
3 Convert human dose in mg/kg to AED in mg/kg by dividing animal dose by Km ratio 
 
 
 Another way to extrapolate a dose required for a given response between species 
is through feed intake. Most of the time this is done on the basis if kcal of energy 
ingested. This process is commonly used and is very straight forward. For example, to 
calculate the necessary dose using this method, one needs to know the energy 
concentration of the diet and the amount of diet consumed on a daily basis. Then, a 
simple calculation reveals the dose based on the kcal of energy ingested. This method 
allows one to use a swine trial to extrapolate an effective dose to a mouse trial or vice 
versa even though mice are very different in size from pigs. This method of scaling doses 
allows researchers to use more cost-effective animal models such as mice to evaluate 
concepts on products intended for larger, more expensive animals. 
45 
 
 Different approaches may be taken to scale doses among different species. 
Kleiber’s Law or the ¾ Power Law was the first approach founded which focuses on 
metabolic body weight. The “dose by factor” approach is similar to Kleiber’s Law where 
they use body surface are but instead of using body weight, correction factors known as 
Km values were developed. A third approach is to calculate doses by the amount of 
calories the animal consumes. This route the simplest and most straightforward approach 
to allometric scaling.  
Summary 
 An intervention is needed to reduce the number of low birth weight and IUGR 
pigs in modern swine production. Low birth weight piglets are becoming an increasingly 
important issue with the selection of highly prolific sows and larger litter sizes. Low birth 
weight piglets (< 1 kg) have a very low likelihood of surviving to weaning. If these 
piglets do survive past weaning, they usually are slow growing and have poor meat 
quality compared with their normal birth weight littermates. This lower efficiency in the 
animal depresses production efficiency and increases cost of production for producers.  
 Mice are a litter bearing species that are affected by IUGR, have short gestation 
lengths, small stature, and are cost effective. Genetically identical mice housed in 
environmentally controlled rooms still express IUGR and birth weight variation is still 
seen. Rats, which have the same placenta as mice, when supplemented with arginine 
during gestation had the same outcomes, of increased litter size and weight, that are 
recorded in sows supplemented with the same thing, even with differences in placentae of 
swine and rodents (i.e. attachment sites and nutrient exchange mechanisms). It is these 
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reasons we believe the mouse can be used as a model for the sow as long as the dose is 
scaled and calculated correctly due to their differences in size to ensure valid results. 
 A nutritional solution may be an effective way to improve the variation in litters 
and reduce the number of low birth weight pigs. Researchers have previously 
investigated different feeding practices (bump feeding) or supplements (arginine, 
glutamine) that can be fed to sows to improve their reproductive performance and 
increase birth weights of piglets. However, this research has yielded contradictory results 
and has not investigated within-litter weight variation. β-hydroxy-β-methylbutyrate is an 
option to increase birth weight due to its positive influences on protein synthesis, protein 
degradation, and hormone production. β-hydroxy-β-methylbutyrate has the potential to 
affect both fetal and placental development.  
 
  
47 
 
Chapter 3 
Evaluation of beta-hydroxy-beta-methylbutyrate (HMB) 
supplementation to mouse dams in gestation on offspring birth weight 
and growth variation 
 
Abstract 
 The objective of this study was to determine if supplementation of mouse dams 
with β-hydroxy-β-methylbutyrate (HMB) calcium salt throughout gestation would 
improve pup birth weight uniformity and improve growth performance of offspring. Data 
were collected from litters of 56 mouse dams and their offspring. Dams were assigned to 
one of 4 treatments; control (CON; n = 13), Low Level HMB (LL; n = 14), High Level 
HMB (HL; n = 15), and Low Level Pulse fed from gestational days 6 to 10 (PUL; n = 
14). A randomly selected subset of 27 dams was euthanized on gestational day 18 to 
collect placentae and pup weights. The remaining dams gave birth and lactated for 28 
days. Offspring were reared until 8 weeks of age. All mice were fed a corn-soy diet, with 
HMB supplementation provided only to dams during gestation. Supplementation of HMB 
had no effects on overall gestation and lactation performance of mouse dams. Dietary 
treatment during gestation did not affect total number of pups born per litter, birth weight 
of pups, or number pups weaned per litter. Variation, expressed as standard deviation and 
coefficient of variation, was not different among treatments for birth weight or weaning 
weight. Range of body weights within litter at birth, weaning, and 8 weeks of age were 
not affected by HMB supplementation. No differences were observed in placental 
weights and size of labyrinth area of the placenta due to dietary treatments. Placental 
efficiency was reduced in the placentae of the LL dams (P < 0.05) compared with CON. 
Overall, offspring growth performance measures such as average daily gain, average 
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daily feed intake and gain to feed were similar among all treatments. Offspring body 
weight at 5 and 8 weeks of age; however, was lower for offspring from the HL dams 
compared to offspring from LL dams (P < 0.05). Body composition of offspring at 5 and 
8 weeks of age was similar regardless of dam HMB supplementation during gestation. In 
conclusion, dietary HMB supplementation of mouse dams during gestation had no effect 
on offspring birth weight, variation in birth weight, or growth performance of offspring. 
 Key Words: birth weight variation, growth performance, HMB, mouse 
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Introduction 
Genetic selection of swine over the years has led to an increase in litter size. Over 
the past 10 years, total pigs born per litter has increased by about 2 pigs/litter from 12.3 
pigs in 2007 to 13.9 pigs in 2017 (Stalder, 2013; Stalder 2018). During this same period 
of time, number of pigs weaned per litter has increased, but not as dramatically, from 9.5 
pigs in 2007 to 10.3 pigs in 2017 (Stalder, 2013; Stalder, 2018). One of the reasons for 
this discrepancy is that there has also been an increase in pre-weaning mortality from 
approximately 14% to 18% in that 10-year span (Stalder, 2013; Stalder 2018). This 
increase in pre-weaning mortality could be a result of increased incidence of intrauterine 
growth retardation and low birth weight pigs. Intrauterine growth retardation (IUGR) is 
defined as the impaired growth and development of mammalian embryos and fetuses or 
its organs during pregnancy (Wu et al., 2006). As litter size increases, available nutrients 
for each fetus decrease due to increased fetal competition. This competition causes 
suboptimal fetal development and as a consequence, lower birthweight and higher within-
litter birthweight variation (Campos et al., 2012). Fetal growth restriction, in utero, can 
cause permanent negative effects on neonatal survival, post-natal growth (Quiniou et al., 
2002) and feed efficiency (Powell and Aberle, 1980), body composition of offspring 
(Hegarty and Allen, 1978; Powell and Aberle, 1980), meat quality of offspring (Gondret 
et al., 2005), and long-term health of pigs (Rooke and Bland, 2002; Le Dividich et al., 
2005). Intrauterine growth retardation will remain a significant problem to the animal 
industry because there is incomplete knowledge of possible solutions for producers to 
employ (Wu et al., 2006).  
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 Fetal growth depends on placental growth and efficiency which are directly 
related to the functional efficiency of delivering nutrients and oxygen to fetuses (Salafia 
et al., 2005). Placental efficiency is influenced by the weight or size of placentae, contact 
surface area with maternal endometrium, placental blood flow, and the ability of the 
placenta to transfer nutrients to fetuses (Ashworth, 2013).  
 Suboptimal maternal nutrition during gestation leads to inability to provide the 
correct amount of nutrients in support of metabolic demands of both sows and fetuses 
(Campos et al., 2012). Fetal growth requires accretion of protein, and when protein is low 
in the maternal diet, fetal weight, and ultimately birth weight can be affected. Therefore, 
researchers are beginning to focus on the use of amino acids or their metabolites as a 
potential dietary intervention to reduce the incidence of IUGR or low birth weight in 
swine. Leucine is an essential amino acid, and its metabolite, β-hydroxy-β-methyl 
butyrate (HMB), could potentially reduce incidence of IUGR and low birth weight pigs.   
In both in vitro and in vivo studies with rats, leucine stimulated muscle synthesis 
(Anthony et al., 2002; Bolster et al., 2004) and inhibited proteolysis in muscle in vitro 
(Buse and Reid, 1975). Similarly, β-hydroxy-β-methylbutyrate also enhanced skeletal 
muscle development and reduced proteolysis (Nissen and Abumrad, 1997; Slater and 
Jenkins, 2000; Wheatley et al., 2014), which suggests potential mechanisms of how HMB 
might reduce the effects of IUGR and incidence of low birth weight pigs.  
Researchers have studied HMB supplementation of sows with various endpoints 
but none have focused on HMB use in gestation diets to increase uniformity of birth 
weight of pigs within litter. Maternal HMB supplementation has improved growth 
performance of offspring in both pigs and lambs (Tatara et al., 2007). Piglets born from 
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sows supplemented with HMB were heavier at birth and had increased daily weight gain 
allowing them to reach market weight faster than pigs farrowed by sows fed un-
supplemented diets (Tatara et al., 2007). Others found that sows fed diets supplemented 
with HMB from 3 to 4 days before parturition through lactation had increased milk fat 
content and heavier piglet weights at weaning, compared to piglets from non-
supplemented sows (Szcześniak et al., 2014). Supplemental HMB also enhanced protein 
synthesis in skeletal muscle of swine neonates (Wheatley et al., 2014).  
Unfortunately, sow studies are difficult to conduct due to length of time, high 
cost, space available and large number of animals needed. Therefore, finding a suitable 
model for sows is helpful. Mice are litter bearing species that are also affected by 
intrauterine growth retardation (Wu et al., 2006). Preliminary data from the University of 
Minnesota showed a 10% coefficient of variation (CV) for birth weight within litter of 
genetically identical mice housed in a controlled environment. The within-litter CV for 
birth weight of pigs can range from 15% to 25% (Wu et al., 2010; Quesnel et al., 2014). 
Therefore, we hypothesized that the mouse could be a reasonable model for the sow to 
evaluate effects of dietary HMB on birth weight variation and growth performance of 
offspring. 
Materials and Methods 
 The experimental protocol used in this study was approved by the Institutional 
Animal Care and Use Committee of the University of Minnesota. 
Animals and Experimental Design 
 This experiment was conducted in a Research Animal Resources Facility on the 
St. Paul campus of the University of Minnesota. Fifty-six post-pubertal, virgin, wild type 
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Agouti Avy (93% C57bl/6 background, isogenic; Weinhouse et al., 2014) dams were used 
to conduct this experiment. Animals were assigned randomly to one of four treatments: 
Control (CON; n = 13), Low Level HMB (LL; n = 14), High Level HMB (HL; n = 15), 
and Pulse (PUL; n = 14). Dams assigned to the PUL treatment received the CON diet 
until day 6 of gestation when they were switched to the LL diet until day 10 of gestation 
then were switched back to the CON diet for the remainder of gestation. Dams in the 
PUL treatment were assumed to be pregnant until pregnancy was confirmed. Days 6 to 
10 of gestation were used for the PUL treatment because formation of the labyrinth 
structure of the placenta occurs during this period in the mouse (Cross et al., 1994). The 
labyrinth structure is the location of nutrient transfer between dam and fetus in the 
mouse. In each treatment, half of the dams were euthanized on gestational day 18 to 
collect each pup and its associated placentae. All dams were housed individually 
throughout the experiment in standard 28 cm x 18 cm x 13 cm plastic cages with corn 
cob bedding and shredded paper for nesting material. Dams were provided ad libitum 
access to feed and water. During breeding, individual males were placed in cages with 
each female and were removed after 24 hours of exposure. Pregnancy was confirmed 14 
days after male exposure based on increased body weight of dams. If dams were not 
pregnant, they were housed with a male again for another 24 hours. Dam body weight 
was collected weekly through the 3-week gestation period and subsequent 4-week 
lactation period. Feed disappearance was recorded weekly for all dams.  
Diet and Treatments 
 Sires and dams received a diet based on corn and soybean meal before breeding. 
The diet was modeled after a sow lactation diet that is commonly used in the commercial 
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swine industry. Diets were blended offsite as a mash (Tables 3.1 and 3.2) and pelleted in 
the lab following standard laboratory procedures developed in Dr. Faulk’s laboratory. In 
brief, 1 kg of diet was mixed with 1,600 mL of water to obtain a thick consistency. The 
diet-water mixture was then pelleted by using the food grinder and sausage stuffer kit for 
a KitchenAid mixer (Pro 600™ Series 6 Quart Bowl-Lift Stand Mixer, Model No. 
KP26M1XER) and placed on baking trays. Trays were then placed in a drying oven for 
approximately 12 hours at 26-32°C. Nutrient concentrations of the experimental diet 
compared to NRC nutrient requirements for mice are shown in Table 3.3. β-Hydroxy-β-
methylbutyrate calcium salt (Ca-HMB; Hefei TNJ Chemical Industry Co., Ltd., Hefei, 
China) was mixed into the CON diet before pelleting. Concentration of HMB in 
experimental diets was determined by Eurofins Microbiology Laboratories, Inc. (Des 
Moines, IA) using an internal HPLC method for analysis.  
 At male exposure, diets fed to dams were switched to the experimental gestation 
diet that was assigned randomly. Dams designated for CON continued to receive the 
CON diet, but dams assigned to the LL and HL treatments were switched to a diet 
containing 3.5 or 35 mg HMB/g diet, respectively. Doses of HMB used in this 
experiment were extrapolated using allometric scaling from the dose used for sows by 
Tatara et al. (2007). Briefly, scaling for the low dose was determined by calculating the 
amount of HMB sows consumed per kcal NE in the study by Tatara et al. (2007). For the 
LL treatment, 4.15 mg Ca-HMB (85%) per gram diet was supplemented to provide 1.4 
mg HMB/kcal NE which equalled the calculated dose used by Tatara et al. (2007). 
Supplementation for HL treatment was 10 times that of the LL treatment. Doses were 
based on energy intake instead of body weight because that scaling by energy intake 
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yields a more accurate dose than if calculated by body weight. Doses calculated by body 
weight can be wrong by a factor of 10 or more (Rucker and Storms, 2002).  
Litter Performance 
 Individual birth weight of pups and total litter weight were recorded within 24 
hours of birth. Following birth, litters were weighed weekly. Body weight was also 
recorded for pups recovered from dams that were euthanized on day 18 of gestation (one 
day before expected parturition).  
Growth Performance of Offspring 
 At weaning, all pups were ear notched individually for identification and sexed. 
All pups were weaned and fed the CON diet and remained on this diet until 8 weeks of 
age. Weaned pups were caged by litter and sex. Individual body weight and feed 
disappearance for each cage were recorded weekly.  
Body Composition 
 At five and eight weeks of age, all pups were transferred to the University of 
Minnesota Phenotyping Core (Minneapolis, MN) for measurement of body composition 
using magnetic resonance imaging (Echo MRI, Echo Medical System; Taicher et al., 
2003). Body weight was recorded at time of scanning. Fat mass, lean mass, and total 
water of live pups were determined. 
Histology 
 On gestational day 18, 28 dams were euthanized using CO2 inhalation to excise 
uterine horns and collect placental tissues and fetuses. Tissue samples were immediately 
placed in a 10% formalin solution for no more than 24 hours to allow tissues to set. After 
24 hours, all tissue samples were rinsed with a PBS solution, transferred to a 70% ethanol 
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solution, and stored at 4°C until submitted for staining. Tissue samples were embedded in 
paraffin using standard histological techniques, sectioned at a thickness of 4 μm, and 
stained with Hemotoxylin and eosin (H&E), which was performed at the Comparative 
Pathology Shared Resource, a core lab of the Masonic Cancer Center at the University of 
Minnesota (Minneapolis, MN). Stained slides were evaluated by light microscopy using 
an Olympus BX53 Microscope (Center Valley, NJ) at 4X power. The CellSense imaging 
software (Olympus, Center Valley, NJ) was used to outline the total labyrinth area.  Area 
of the labyrinth was determined in two separate tissue sections for each placenta. The 
average measurement of two sections was recorded for the area of the labyrinth. 
Measurements were completed by the same individual that was blinded to treatments to 
reduce variation. This analysis was completed on 208 placentae collected. 
Statistical Analysis 
 For all analyses, the GLIMMIX procedure of SAS (SAS Inst. Inc., Cary, NC) was 
used. Breeding group was included in all the following statistical models as a random 
effect. Breeding group was designated as the contemporary group of dams that were 
successfully mated during a given 2-week breeding period. Results are reported as least 
squares means, and comparisons among treatments were performed using the PDIFF 
option of SAS with the Tukey-Kramer adjustment for multiple comparisons. Treatment 
effects were considered significant if P < 0.05 and a trend if 0.1 > P ≥ 0.05. 
 Dam and litter performance data were analyzed as a completely randomized 
design. Individual dam served as the experimental unit. The statistical model for dam and 
litter performance included dietary treatment as a fixed effect.  
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 To further evaluate birth weight, birth weight categories were used to analyze 
individual birth weights of pups. The two heaviest and two lightest birth weights per litter 
were designated to either the high or low birth weight category, respectively. Birth 
weight, placental weight, placental efficiency (ratio of fetal weight:placental weight), and 
labyrinth area were analyzed using a statistical model that included fixed effects of 
dietary treatment, birth weight category, and their interaction. A second statistical model 
was used to analyze these same traits except that birth weight category was nested within 
dietary treatment.  
 To investigate differences in variation of birth weight, weaning weight, and body 
weight of offspring at 8 weeks of age, standard deviations of each litter, ranges 
(difference between lightest and heaviest birth weight), and the differences between the 
median and the lightest birth weight from each litter were calculated and compared 
among treatments. This analysis was repeated with litters that contained 8 pups or 
greater. Litters of 8 pups or more were considered to be large litters because they 
contained at least two more pups than the mean litter size for this mouse strain (Verley et 
al., 1967; Johnston et al., 2007). 
 Repeated measures analysis was used to determine effects of dam treatment 
during gestation on offspring performance and body composition from weaning to eight 
weeks of age. The statistical model for offspring performance and body composition 
included time (weeks), dietary treatment of dams, sex and the interactions of all three 
factors. 
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Results 
Dam Performance in Gestation and Lactation 
 Dietary treatment had no effect on overall gestation or lactation performance of 
dams (Table 3.4). There was no effect of HMB on body weight during the first two weeks 
of gestation (Table 3.5); however, in the third week of gestation, body weight of dams 
assigned to PUL tended to be greater than body weight of dams assigned to HL (P < 
0.10). Dietary treatment had no effect on dam ADG and ADFI. An interaction (P < 0.01) 
was found between treatment and stage of gestation for ADFI of dams. There were no 
differences in ADFI among treatments in the first two weeks of gestation but in the third 
week, dams assigned to HL had a lower ADFI than LL and PUL dams (P < 0.01). A 
decrease in ADFI was observed from week 2 to week 3 of gestation in dams assigned to 
HL while all other dams increased ADFI during this time (Figure 3.1).  During the 4-
week lactation period there were no differences among dietary treatments for body 
weight, ADG, and ADFI and no significant interactions among dietary treatments and 
stage of lactation (Table 3.6).  
Litter Performance 
 There were no effects of dietary treatment during gestation on total number born 
alive per litter, number weaned per litter, average pup birth weight, litter birth weight or 
litter weight at weaning (Table 3.7). Supplementation of HMB to dams during gestation 
had no effect on placental weight or labyrinth area (Table 3.8). Placental efficiency, 
however, was lower (P < 0.05) in LL dams compared to CON dams while dams assigned 
to PUL and CON treatments tended to have a higher placental efficiency than the LL and 
HL dams (P < 0.10). 
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 No differences were observed among treatments within birth weight categories for 
weight (combined fetal and birth), placental efficiency, or labyrinth area (Table 3.9). 
Placental weights in the low weight category tended to be higher in PUL dams compared 
to CON dams (P < 0.10). Similar results were observed when using a statistical model 
that nested birth weight category within dietary treatment (Table 3.10). 
 Statistical analysis of diet effects on birth weight and placental traits were 
repeated with uterine horn included in the model (Table 3.11). Weights (combined fetal 
and birth) of offspring from LL and HL dams were lower than weights from dams of 
CON and PUL treatments in the right uterine horn only (P < 0.05). Placental weights and 
labyrinth area were similar among treatments within each uterine horn. There was a 
tendency for placental efficiency in the right uterine horn of PUL and CON dams to be 
greater than LL dams (P < 0.10). Similar results were observed when the statistical 
analysis nested uterine horn within treatment (Table 3.12). 
 Pups born from HL dams that completed term had a lower birth weight than pups 
from CON dams (P < 0.01; Table 3.13). Pups retrieved from euthanized dams of the PUL 
group had greater weight than the pups of HL- and LL-supplemented dams (P < 0.01). 
 Variance in birth weight within litter expressed as either CV or SD was not 
affected by dietary treatment of dams during gestation (Table 3.14). Variance in weaning 
weight among litters expressed either as CV or SD was not affected by dam treatment 
during gestation. Ranges, calculated by the difference between the heaviest and lightest 
pup in each litter at birth and weaning, were not different among treatments. However, at 
8 weeks of age, offspring of LL dams had a lower range in body weight per litter than 
offspring of HL dams (P < 0.05). The difference between the median weight of each litter 
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and the lightest pup of that litter, noted as lower half, were similar among treatments at 
birth, weaning, and 8 weeks of age. Measurements of variance including within litter 
birth weight CV, within litter wean weight CV, and values of SD, range, and lower half 
for birth weight, pup weaning weight, and body weight at 8 weeks of age in litters 
containing 8 or more pups were not influenced by dietary treatments (Table 3.15). 
Growth Performance of Offspring 
 Dietary treatments fed to dams during gestation had no effects on overall 
performance of offspring (Table 3.16). In weeks 1 to 4 post-weaning, offspring from LL 
dams had a greater body weight than offspring of HL dams (P < 0.05; Table 3.17). There 
was no effect of dietary treatments during the 4 weeks post-weaning on average daily 
gain  (ADG); however, there was a significant treatment by week post-weaning 
interaction (P = 0.02). During the first week post-weaning, offspring from PUL dams had 
greater ADG than those from all other treatments, but this advantage was lost during the 
second week when PUL offspring had a lower ADG than both CON and HL offspring. 
During the 4 weeks post-weaning, a dietary treatment trend (P = 0.10) and significant 
effect of time (P < 0.01) were observed for gain to feed ratio (G:F). Offspring from HL 
and PUL dams displayed a greater G:F than LL offspring during the first week post-
weaning. However, during week two, G:F decreased for PUL offspring and was lower 
than that of HL offspring. There were no differences in G:F among treatments during 
weeks 3 or 4 post-weaning.  
 Males and females had similar body weights at weaning. However, in weeks 1 to 
4 post-weaning, males had heavier body weights than females (P < 0.05; Table 3.18). 
Throughout the 4-week growth period post-weaning, males had greater ADG than female 
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offspring (P < 0.01). Average daily feed intake was similar between males and females in 
the first week post-weaning but became greater in males in weeks 2 to 4 (P < 0.05). 
During weeks 1 and 3, male offspring expressed a greater G:F than female offspring (P < 
0.05). There was no significant interaction between sex, dam dietary treatment and week 
post-weaning for body weight, ADG, ADFI, or G:F (Table 3.19). 
Body Composition 
 Offspring from LL dams were significantly heavier at the 5-week body scan than 
offspring from CON and HL dams. At this time, CON offspring were also heavier than 
HL offspring (P < 0.05; Table 3.20). At the 8 week body scan, LL offspring continued to 
be heavier than those from all other dietary treatments (P < 0.05). Lean mass percentage 
at 5 weeks of age was greater in HL offspring than LL and PUL (P < 0.05). At 8 weeks of 
age, lean mass percentage in HL continued to be greater than LL offspring (P < 0.05). No 
differences were observed in fat mass at 5 weeks of age. However, at 8 weeks of age, 
offspring from LL group had a higher fat mass percentage than offspring from PUL dams 
(P < 0.05). Dam dietary treatment did not affect total water percentage of offspring at 5 
weeks of age. At 8 weeks, offspring of PUL dams had a higher total water percentage 
than offspring of LL dams (P < 0.01). At both body scans, males had a heaver body 
weight than females (P < 0.01; Table 3.21). There were no sex differences in lean mass 
percentage at either body scan. Females had a greater fat mass percentage than males at 
the 5-week body scan; however, these results were reversed at the 8-week body scan (P < 
0.02). No differences were observed in total water percentage between males and females 
at either body scan. No significant interaction among sex, dam dietary treatment and 
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week of body composition scan for body weight, lean mass percentage, fat mass 
percentage, and total water percentage was observed (Table 3.22).  
Discussion 
 A comparison between the mouse and sow can be found in Table 3.23. These 
animals are both litter bearing species that are both affected by variation in litter size. The 
strain of mice that were used in this experiment have a within-litter birth weight variation 
of 10%. This is lower than the range that has been recorded in sows of 15% to 25% (Wu 
et al., 2010; Quesnel et al., 2014). The range for sows is considerably larger than the 
mouse, however the range of variation for the sow contains genetic variation, 
environmental variation, and inherent variation whereas the variation reported in the 
mouse strain in only the inherent variation due because the mice are genetically identical 
and were housed in a tightly controlled environment.  
 No adverse effects on sow performance during gestation, lactation, or subsequent 
reproductive cycles have been reported when supplementing HMB to sows during late 
gestation and lactation (Nissen et al., 1994). In the current study, the lack of a positive or 
negative response to dietary HMB supplementation on mouse dam performance during 
gestation and lactation observed in the present study was expected.  
 In the third week of gestation, we noted a decrease in feed intake of dams in the 
HL group. It is possible that the high HMB inclusion created an aversion to the diet that 
caused the decline in feed intake. However, if an aversion to a high concentration of 
HMB existed, we would have expected to see the decline in feed intake when diets were 
first introduced and not after 2 weeks of consumption. Baxter et al. (2005) fed rats 5% 
dietary HMB for 90 days and reported that 5% inclusion in the diet was the no-observed-
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adverse-effect level. Therefore, we would not expect the HL dose at 4.3% of the diet to 
decrease feed intake. However, the rats used by Baxter et al. (2005) were not pregnant or 
lactating. As a result, there may have been an interaction between the high concentration 
of dietary HMB and pregnancy in the present experiment that resulted in depressed feed 
intake. Furthermore, body weights of the mouse dams were not different among dietary 
treatments during gestation until the third week when dams fed HL had a lower body 
weight. This reduction in body weight was most likely caused by the reduction in feed 
intake observed for HL dams during this same time period. 
 Birth weight of pups was not affected by maternal HMB supplementation during 
gestation. These findings are in agreement with previous research conducted in swine 
(Nissen et al., 1994; Flummer and Theil, 2012; Flummer et al., 2012). However, other 
studies have reported an increase in birth weight from maternal HMB supplementation in 
pigs (Tatara et al., 2007; Tatara et al., 2012; Wan et al., 2016b). Mixed results of HMB 
on birth weight may be due to the varying lengths of feeding HMB supplemented diets. 
Swine studies with positive results began supplementation two weeks before farrowing 
(Tartara et al., 2007; Tatara et al., 2012) or even as early as day 35 of gestation through 
farrowing (Wan et al., 2016b). In previous swine trials where no differences in birth 
weight were observed, dietary HMB supplementation was provided only 3 to 10 days 
before farrowing (Nissen et al. 1994; Flummer et al. 2012), leading to the thought that 
supplementation occurred too late in gestation for any effect on birth weight to be 
observed. In the current study, supplementation was either constant throughout the entire 
gestation period or only during a critical time in placental development. Therefore, we 
expected to observe a positive effect of maternal HMB supplementation on pup weight at 
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the end of gestation. No previous studies in mice have been published where mouse dams 
were supplemented with HMB during gestation to observe birth weight of pups. 
 Another potential reason for mixed results in previous trials may have been due to 
the wide range of doses for Ca-HMB that have been fed. In the studies were HMB 
supplementation had no effect on birth weight, sows were supplemented with 2 to 3 g 
HMB/day. This range of doses equates to 0.10 to 0.14% of the total diet. This level of 
supplementation is considerably lower than the low dose used in the current study. The 
swine studies showing positive results supplemented 4 grams per sow per day (Wan et 
al., 2016b) or about 7 grams of HMB per sow per day (Tatara et al., 2007; Tatara et al., 
2012) which is 0.19% and 0.33% of the diets, respectively. In studies published 
previously, concentrations of HMB in the Ca-HMB products used were not reported. It is 
difficult to know the exact amount of HMB supplemented in the previous studies because 
concentrations of Ca-HMB products range from 80% HMB to 99% HMB. The product 
used in our study had a HMB concentration of 85%. This could have led to a lower dose 
of HMB than what has been supplemented in previous studies. This could also be a 
reason why no response to HMB supplementation was observed in the current study. 
With our product at 85% HMB, the LL dose in the present study provided 0.35% HMB in 
the diet. The 0.19% and 0.33% listed above is the percentage of total product that was 
used and not necessarily the amount of HMB that was supplemented. It is difficult to 
compare this dose to the doses used previously because no HMB concentrations of 
products were reported. Therefore, in the studies where positive results were reported, 
HMB levels could have differed from 0.19 or 0.33% of the diet that it was believe it to 
be. 
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 Supplementation of dam diets with HMB had no effect on within-litter variation 
of birth weight recorded as both standard deviation of birth weights and within-litter birth 
weight coefficient of variation (CV). These results are in agreement with the observations 
of Wan et al. (2016b). We hypothesized that HMB would increase uniformity of within-
litter pup birth weights. β-hydroxy-β-methylbutryate can increase endogenous levels of 
growth hormone (Tatara et al., 2007; Tatara et al., 2012). When providing sows with 
exogenous growth hormone, fetal and placental weights increased (Sterle et al., 1995). 
Growth hormone has also been shown to selectively improve the uterine environment for 
smaller pigs in utero by influencing placental nutrient transfer and placental growth 
(Rehfeldt et al., 2001). Supplementing HMB from day 35 of gestation through parturition 
reduced the percentage of piglets born weighing less than 1 kg body weight compared to 
unsupplemented sows (Wan et al., 2016b). β-hydroxy-β-methylbutryate can increase the 
activity of the GH/IGF-1 axis (Tatara et al., 2007; Kornasio et al., 2009; Gerlinger-
Romero et al., 2011; Tatara et al., 2012). If growth hormone selectively improves growth 
conditions for smaller piglets in utero, then this may be a potential mechanism to reduce 
the incidence of low birth weight pigs from sows fed diets supplemented with HMB. For 
these reasons, we hypothesized that HMB could potentially reduce the within-litter 
variation in pup weight at birth. However, we did not observe this response, which could 
potentially be due to using a non-efficacious dose of our HMB product. We did not 
measure growth hormone in this present study so it is unknown if dietary 
supplementation at the doses provided had any effect on endogenous growth hormone 
levels in the mice. 
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 In the current study, birth weight was higher than fetal weight recorded on 
gestational day 18. Weights differed between gestational day 18 and birth at gestational 
day 19 by about 25-30%. We believe that this increase in weight between days is due to 
gestational gain during the last day of gestation and intake of colostrum after birth 
because birth weights were recorded after pups had suckled. However, all measurements 
of birth weight variation evaluated were not influenced by treatment no matter if they 
were from litters born on day 19 or litters removed from the dam at gestational day 18.   
 It is unknown if HMB can be transferred across the placenta to the fetus. 
However, if HMB does not cross the placenta and act directly on the fetus it may still 
have an indirect effect. One indirect effect would be to influence placental development 
by increasing the labyrinth area or placental weight. In the current study, we did not find 
any differences in placental development with HMB supplementation. Although placental 
development, labyrinth area, and placental weight, were not affected, this does not mean 
that placental function, such as increasing nutrient transporters in the placenta, could not 
have been influenced. The increase in the activity of GH/IGF-1 axis, caused by HMB has 
potential to affect placental function because an increase of IGF-1 expression increases 
amino acid transporters on the placenta (Vaughan et al., 2017). An increase in placental 
amino acid transporters allows more amino acids to be transferred to the fetus potentially 
leading to greater fetal growth. Tatara et al. (2012) observed increased circulating 
glutamine, glycine, valine, and tyrosine in newborn piglets from HMB-supplemented 
sows. In the current study, the crude measurement of placental efficiency (fetal 
weight:placental weight ratio) was not improved in HMB-supplemented dams compared 
with CON dams. However, this does not mean that placental function was not affected. 
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Placental amino acid transporters and nutrient flux were not measured in this study. 
Future research may explain any potential effects of HMB on placental function such as 
increasing placental nutrient transporters.  
 Weaning weights of offspring were not different among treatments in this study. 
Previously, researchers noted that pigs from dams supplemented with HMB during late 
gestation through lactation had heavier weaning weights even if there were not 
differences in birth weights (Nissen et al., 1994). The increase in weaning weight with 
HMB supplementation may be a result of an increase in milk fat percentage in HMB 
supplemented sows (Nissen et al., 1994; Flummer and Theil, 2012; Wan et al., 2016b). 
The increase in milk fat could have increased the energy intake of the offspring leading to 
advanced growth over the offspring from un-supplemented sows that had a lower milk fat 
percentage. The mouse offspring in the present study may not have had different weaning 
weights because all dams were fed the same basal diet during lactation with no HMB 
supplemented.  
 No differences in overall growth performance measures, ADG, ADFI, or G/F, 
among treatments were observed. In the present study, body weight of the mice at 8 
weeks of age was greatest in the LL group, but was not different among all other 
treatments. This response is different from the results observed by Wan et al. (2017) 
where pigs from sows supplemented with HMB during lactation displayed a greater 
weight at market, increased ADG, and a tendency for decreased F/G compared to pigs 
from unsupplemented sows. Other researchers have included HMB in diets of meat 
animals in the growing and finishing phases. In steers, supplementing HMB in diets fed 
82 days before market, increased ADG and feed intake and improved feed efficiency 
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when steers were slaughtered at 105 days of age (Van Koevering et al., 1994). In broiler 
chickens, supplemental HMB at 0.1% increased ADG compared to birds on a control diet 
(Qiao et al., 2013). In pigs, offspring from sows fed HMB were heavier at slaughter than 
the control pigs (Wan et al., 2017). Broiler chickens fed diets supplemented with HMB 
also had an increase in final body weight (Qiao et al., 2013). In these studies, animals 
were fed HMB during the growth period. In our study, the offspring did not receive HMB 
after birth and therefore, this may be a reason why we did not see the same results in our 
experiment. 
 One of the mechanisms of action of HMB is increased protein synthesis and 
reduced proteolysis (Ostaszewski et al., 2000; Holecek et al. 2009; Pimentel et al., 2011; 
Wheatley et al., 2014; Wan et al., 2016a). Body composition of the mouse offspring was 
not altered by maternal HMB supplementation in this experiment. This is different than 
what researchers have previously reported in other species. Pigs from sows fed HMB had 
a higher lean meat percentage at slaughter than the pigs from control sows (Tatara et al., 
2007; Wan et al., 2017). In broiler chickens, increased breast yield and reduced 
abdominal fat were observed at both 21 and 42 days of age with HMB supplementation 
(Qiao et al., 2013). In steers, less subcutaneous fat and improved marbling scores were 
observed when feeding HMB (Van Koevering et al., 1994). In all of these previous 
studies, with the exception of Tatara et al., 2007, animals received HMB supplementation 
during the growth period. The mice in the current study were not fed HMB after birth, 
which may be a reason why no effects on body composition were observed. 
 Prior to conducting this study, we believed that the mouse dam would be a 
suitable model for the sow. Mice are susceptible to IUGR and variation in birth weights, 
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even when they are genetically identical and housed under tightly controlled, constant 
environments. There are differences in placentae between the mouse and the sow. Mice 
have a discoidal placenta with a labyrinth system for maternal and fetal nutrient 
exchange, while the sow has a diffuse placenta and a cross-current system for maternal 
and fetal nutrient exchange. Even though they have different placentae structures, the 
placentae are affected in a similar manner after GH/IGF-1 intervention. In both placental 
types, GH/IGF-1 increases the placental gene expression of Slc38a2, a gene for a neutral 
amino acid transporter in the tissue (Sferruzzi-Perri et al., 2007a, b; Tung et al., 2012). 
Therefore, the mouse dam may be a suitable model for the sow. However, more research 
needs to be conducted to confirm this model by determining nutrient uptake transporters 
of both placental types and if both placental types are affected similarly by different 
interventions. 
 In this study, we may have not observed the anticipated results because the HMB 
dose may not have been adequate to observe potential responses, but none of the previous 
studies reported concentrations of the Ca-HMB product that was being used to serve as a 
reference. Therefore, we could have over- or underestimated the amount of HMB that 
those animals were receiving when calculating our dose of HMB. Another potential 
reason is that it is unknown if HMB can be passed through the placenta to allow HMB to 
directly affect the offspring in utero.  
 In conclusion, maternal diet HMB supplementation had no effects on mouse dam 
performance in gestation or lactation, pup birth weight, variation in weight at birth and 
weaning, overall growth performance, or body composition of offspring. These results 
are contrary to those in previous animal studies where β-hydroxy-β-methylbutyrate 
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improved birth weight, as well as offspring growth performance and carcass composition 
when supplemented during the growing period. Concentrations of Ca-HMB used in 
previous research needs to be confirmed to evaluate if proper dosing was applied in this 
experiment or if a different dose will give different results. Researchers also need to 
determine if HMB can be transferred through the placenta or only through milk to act 
directly on the offspring, or if HMB has an indirect effect on offspring growth by altering 
placental development during gestation. 
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Table 3.1.  Diet Composition, as fed % 
 Diet 
Nutrient CON LL HL 
Corn, Ground 63.19 62.92 60.47 
Soybean meal, 46.5% CP 29.30 29.17 28.04 
Mineral Mix1 3.50 3.48 3.35 
Vitamin Mix2 1.00 1.00 0.96 
Calcium carbonate 0.27 0.27 0.26 
Choline chloride 0.20 0.20 0.19 
Soy Oil 2.55 2.54 2.44 
    
Ca-HMB3, 85% HMB 0.00 0.43 4.30 
1Contained the following ingredients per kg of premix: calcium carbonate, 357 g; 
potassium phosphate, monobasic, 196 g; potassium citrate, H2O, 70.78 g; sodium 
chloride, 74 g; potassium sulfate, 46.6 g; magnesium oxide, 24 g; ferric citrate, U. 
S. P., 6.06 g; zinc carbonate, 1.65 g; manganous carbonate, 0.63 g; cupric 
carbonate, 0.3 g; potassium iodate, 0.01 g; sodium selenite, 10.25 mg; ammonium 
paramolybdate, .4 H2O, 7.95 mg; sodium metasilicate, .9 H2O, 1.45 g; chromium 
potassium sulfate, .12 H2O, 0.275 g; lithium chloride, 17.40 mg; boric acid, 81.50 
mg; sodium fluoride, 63.50 mg; nickel carbonate, 31.80 mg; ammonium vanadate, 
6.60 mg. 
2Contained the following ingredients per kg of premix: niacin, 3.0 g; calcium 
pantothenate, 1.60 g; pyridoxine HCl, 0.70 g; thiamine HCl, 0.60 g; riboflavin, 
0.60 g; folic acid, 0.20 g; biotin, 0.02 g; vitamin E acetate, 7500 IU; vitamin B12, 
0.1%, 2.50 g; vitamin A palmitate, 400,000 IU; vitamin D3, 100,000 IU; vitamin 
K1, 75 mg. 
3Sourced from Hefei TNJ Chemical Industry Co.,Ltd., Hefei, China. HMB was 
mixed with control diet before pelleting. 
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Table 3.2.  Calculated nutrient composition of experimental diets (as fed) 
  Diet  
Nutrient CON LL HL 
Dry matter, % 87.87 87.50 84.21 
NE, kcal/kg 2,492.30 2481.60 2385.10 
Crude protein, % 18.00 17.92 17.23 
Crude fat, % 5.00 4.98 4.89 
    
Amino acids:    
Lys, total % 1.05 1.04 1.00 
Thr, total % 0.69 0.68 0.66 
Met + Cys, total % 0.57 0.56 0.54 
Trp, total % 0.24 0.24 0.23 
Ile, total % 0.81 0.80 0.77 
Val, total % 0.90 0.90 0.87 
Arg, total % 1.15 1.14 1.10 
His, total % 0.48 0.48 0.46 
Leu, total % 1.59 1.59 1.53 
Phe + Tyr, total % 1.16 1.15 1.10 
    
Minerals:    
Calcium, total % 0.76 0.82 1.42 
Phosphorus, total % 0.54 0.54 0.52 
Sodium, % 0.12 0.12 0.12 
Chlorine, % 0.19 0.19 0.18 
Magnesium, % 0.18 0.18 0.18 
Potassium, % 1.17 1.16 1.12 
Copper, mg/kg 12.00 12.00 12.00 
Iron, mg/kg 101.00 100.00 97.00 
Manganese, mg/kg 25.00 25.00 24.00 
Zinc, mg/kg 57.00 57.00 54.00 
    
Vitamins:    
A, IU/kg 5,079 5,076 4,874 
D, IU/kg 1,001 1,001 961 
E, IU/kg 89 89 86 
K, mg/kg 0.75 0.75 0.72 
Riboflavin, mg/kg 7.46 7.45 7.15 
Niacin, mg/kg 49.71 49.62 47.66 
Pantothenic acid, mg/kg 16.00 15.95 15.73 
Choline, mg/kg 2,530.05 2,523.46 2,414.32 
Biotin, mg/kg 0.34 0.34 0.33 
B-12, mg/kg 0.02 0.02 0.02 
Folic acid, mg/kg 2.28 2.28 2.28 
Pyridoxine, mg/kg 6.99 6.99 6.99 
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Thiamin, mg/kg 8.14 8.13 8.14 
    
HMB, mg/g 0.00 3.50 35.00 
    
Analyzed nutrients: 
HMB, mg/g     0.00 6.12 36.80 
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Table 3.3. Comparison of experimental diet to nutrient requirements of mice (as fed) 
  Diet  
Nutrient CON NRC1 
Dry matter, % 87.87 - 
NE, kcal/kg 2,492.30 - 
Crude protein, % 18.00 18.00 
Crude fat, % 5.00       5.00 
   
Amino acids:   
Lys, total % 1.05 0.40 
Thr, total % 0.69 0.40 
Met + Cys, total % 0.57 0.50 
Trp, total % 0.24 0.10 
Ile, total % 0.81 0.40 
Val, total % 0.90 0.50 
Arg, total % 1.15 0.30 
His, total % 0.48 0.20 
Leu, total % 1.59 0.70 
Phe + Tyr, total % 1.16 0.76 
   
Minerals:   
Calcium, total % 0.76 0.50 
Phosphorus, total % 0.54 0.30 
Sodium, % 0.12 0.05 
Chlorine, % 0.19 0.05 
Magnesium, % 0.18 0.05 
Potassium, % 1.17 0.20 
Copper, mg/kg 12.00 6.00 
Iron, mg/kg 101.00 35.00 
Manganese, mg/kg 25.00 10.00 
Zinc, mg/kg 57.00 30.00 
   
Vitamins:   
A, IU/kg 5,079 2,398 
D, IU/kg 1,001 998 
E, IU/kg 89  31 
K, mg/kg 0.75 0.99 
Riboflavin, mg/kg 7.46  7.05 
Niacin, mg/kg 49.71 14.99 
Pantothenic acid, mg/kg 16.00 15.87 
Choline, mg/kg 2,530.05 1,999.59 
Biotin, mg/kg 0.34 0.20 
B-12, mg/kg 0.02 0.009 
Folic acid, mg/kg 2.28 0.51 
Pyridoxine, mg/kg 6.99 7.94 
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Thiamin, mg/kg 8.14 5.07 
1Nutrient Requirements of Laboratory Animals: Fourth Revised Edition, 1995. 
Washington (DC): National Academies Press (US); 1995. 3, Nutrient Requirements of 
the Mouse. 
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Table 3.4.  Overall dam performance during gestation and lactation by treatment 
 Treatments   
Trait CON LL HL PUL SE P Value 
No. of dams 13 14 15 14 - - 
No. of cages 13 14 15 14 - - 
BW at mating, g 20.64 20.04 20.08 20.39 0.49 0.81 
BW after birth1, g 25.61 25.41 23.39 24.76 0.83 0.16 
BW at weaning1, g 27.58 27.02 26.72 27.14 0.87 0.89 
Gestation:       
   ADG, g 0.25 0.28 0.16 0.27 0.05 0.21 
   ADFI, g 4.40 4.27 4.12 4.38 0.28 0.76 
Lactation2:       
   ADG1, g 0.05 0.06 0.12 0.09 0.04 0.61 
   ADFI1, g 9.09 9.15 8.98 10.34 0.74 0.27 
1Number of dams per treatment used in analysis: CON, n = 6; LL, n = 7; HL, n = 8; PUL, n = 7.  
228 day lactation period. 
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Table 3.5. Effect of dietary treatment on gestation performance of dams  
 Treatments  P value 
Trait CON LL HL PUL SE Trt1 Trt*Time2 
No. of dams 13 14 15 14 - -  
 Avg. body weight, g 1.32 0.01 0.60 
   Week 1 21.07 20.53 20.44 21.05    
   Week 2 24.55 23.84 22.61 24.82    
   Week 3 32.03xy 30.99xy 29.27x 33.66y    
Avg. daily gain, g 0.12 0.18 0.94 
   Week 1 0.07 0.03 0.06 0.13    
   Week 2 0.50 0.47 0.34 0.54    
   Week 3 1.24 1.09 1.07 1.32    
Avg. daily feed intake, g 0.37 0.75 < 0.01 
   Week 1 4.31 4.16 4.37 3.56    
   Week 2 4.07 3.70 4.14 3.61    
   Week 3 4.20ab 4.70a 3.46b 4.88a    
1Dietary treatment. 
2Dietary treatment by stage of gestation interaction. 
abMeans within a row with different superscripts differ (P < 0.05). 
xyMeans within a row with different superscripts differ (P < 0.10). 
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Figure 3.1 Interaction of dietary treatments and stage of gestation for ADFI of dams 
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Table 3.6.  Effect of dietary treatment on lactation performance of dams  
 Treatments  P value 
Trait CON LL HL PUL SE Trt1 Trt*time2 
No. of dams 6 7 8 7 - - - 
Avg. body weight, g 1.33 0.12 0.66 
   Week 1 27.10 28.12 25.23 27.75    
   Week 2 29.02 29.22 26.72 28.02    
   Week 3 27.44 27.86 27.75 26.28    
   Week 4 28.56 29.04 27.97 27.52    
Avg. daily gain, g 0.21 0.54 0.42 
   Week 1 -0.02 0.33 0.78 0.40    
   Week 2 0.28 0.17 0.20 0.03    
   Week 3 -0.22 -0.18 0.14 -0.25    
   Week 4 0.26 0.30 0.02 0.31    
Avg. daily feed intake, g 1.08  0.44 0.79 
   Week 1 6.36 7.89 6.90 7.94    
   Week 2 8.63 9.88 9.32 9.69    
   Week 3 11.45 10.70 11.01 11.30    
   Week 4 10.41 11.23 13.16 12.58    
1Dietary treatment. 
2Dietary treatment by stage of gestation interaction. 
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Table 3.7. Effect of dietary treatment on pre-weaning performance of litters 
 Treatments   
Trait CON LL HL PUL SE P value 
No. of litters, total 13 14 15 14 - - 
No. of litters, weaned 6 8 8 7 - - 
No. of pups, total 99 102 111 112 - - 
No. of pups, weaned 40 55 61 53 - - 
Total born alive per litter 7.55 7.16 7.51 7.82 0.51  0.71 
Number weaned per litter 7.55 6.85 7.34 7.77 0.55 0.42 
Avg. pup birth weight, g 1.18 1.16 1.13 1.19 0.07 0.81 
Avg. pup wean weight, g  11.11xy 11.89x 11.15xy 10.44y 0.58 0.11 
Litter birth weight, g 8.80 8.42 8.40 9.44 0.59 0.52 
Litter wean weight, g 78.40 79.72 82.38 80.34 6.77 0.95 
xyMeans within a row with different superscripts differ (P < 0.10). 
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Table 3.8. Effect of dietary treatments on placental characteristics 
 Treatments   
Trait CON LL HL PUL SE P value 
No. of litters 7 6 7 7 - - 
No. of pups 59 43 48 58 - - 
Placental weight, g 0.24 0.24 0.24 0.25 0.008 0.47 
Placental efficiency1 4.415a,x 3.967b,y 3.971ab,y 4.353ab,x 0.20 < 0.01 
Labyrinth area, mm2 5.10 5.17 5.06 5.03 0.16 0.89 
1Placental efficiency = (fetal weight / placental weight). 
abMeans within a row with different superscripts differ (P < 0.05). 
xyMeans within a row with different superscripts differ (P < 0.10). 
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Table 3.9.  Effect of dietary treatment on fetal weight and placental characteristics across birth weight categories1 
 Treatments  P value 
Trait CON LL HL PUL  SE Trt2 Trt*BirthWtCat3 
No. of litters4 13 14 15 14 - - - 
Weight4,5, g     0.07 0.11 0.98 
   High 1.28 1.28 1.22 1.32    
   Low 1.11 1.07 1.03 1.12    
Placental weight6, g     0.01 0.17 0.13 
   High 0.259 0.256 0.249 0.258    
   Low 0.222y 0.233xy 0.234xy 0.257x    
Placental efficiency6,7     0.35 0.22 0.62 
   High 4.40 4.03 4.19 4.50    
   Low 4.32 3.86 3.80 3.90    
Labyrinth area6, mm2     0.25 0.65 0.37 
   High 5.21 4.92 4.95 4.98    
   Low 4.87 4.85 5.21 4.87    
1Birth weight categories were determined by selecting two heaviest and two lightest weights of pups within each litter for the high 
and low categories, respectively. 
2Dietary treatment. 
3Interaction of dietary treatment and birth weight category. 
4Contains birth weights and fetal weights from pups euthanized at gestational day 18. 
5No. of litters: CON = 13; LL = 14; HL = 15; PUL = 14.  
6No. of litters: CON = 7; LL = 6; HL = 7; PUL = 7.  
7Placental efficiency = (fetal weight / placental weight). 
xyMeans within a row with different superscripts differ (P < 0.10). 
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Table 3.10.  Effect of dietary treatment and weight category nested within diet on fetal weight and placental characteristics1 
 Treatments  P value 
Trait CON LL HL PUL  SE BirthWtCat(trt)2 
No. of litters3 13 14 15 14 - - 
Weight3,4, g     0.07 0.98 
   High 1.28 1.28 1.22 1.32   
   Low 1.11 1.07 1.03 1.12   
Placental weight5, g     0.01 0.13 
   High 0.259 0.256 0.249 0.258   
   Low 0.221y 0.233xy 0.234xy 0.257x   
Placental efficiency5,6     0.35 0.62 
   High 4.40 4.03 4.19 4.50   
   Low 4.32 3.86 3.80 3.90   
Labyrinth area5, mm2     0.25 0.37 
   High 5.21 4.92 4.95 4.98   
   Low 4.87 4.85 5.21 4.87   
1Birth weight categories were determined by selecting two heaviest and two lightest weights of pups within each litter for the high 
and low categories, respectively. 
2Weight category nested within diet. 
3Contains birth weights and fetal weights from pups euthanized at gestational day 18. 
4No. of litters: CON = 13; LL = 14; HL = 15; PUL = 14.  
5No. of litters: CON = 7; LL = 6; HL = 7; PUL = 7.  
6Placental efficiency = (fetal weight / placental weight). 
xyMeans within a row with different superscripts differ (P < 0.10). 
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Table 3.11.  Effect of dietary treatments and uterine horn on fetal weight and placental characteristics 
 Treatments  P value 
Traits CON LL HL PUL SE Trt2 Horn3 Trt*Horn4 
No. of litters 7 6 7 7 - - - - 
No. of mice 59 43 48 58 - - - - 
Fetal weight, g     0.04 < 0.01 0.61 0.45 
   Right 1.02a 0.94b 0.95b 1.08a     
   Left 1.01 0.95 0.97 1.02     
Placental weight, g     0.009 0.64 0.01 0.64 
   Right 0.234 0.243 0.235 0.243     
   Left 0.246 0.245 0.253 0.253     
Placental efficiency1     0.23 < 0.01 0.03 0.53 
   Right 4.52x 3.96y 4.07xy 4.59x     
   Left 4.24 3.97 3.83 4.12     
Labyrinth area, mm2     0.20 0.82 0.71 0.06 
   Right 5.20 5.19 5.14 4.79     
   Left 4.93 4.77 5.18 2.25     
1Placental efficiency = (fetal weight / placental weight).  
2Dietary treatment. 
3Uterine horn pup was removed from. 
4Interaction of dietary treatment and uterine horn in which pup was removed from. 
abMeans within a row with different superscripts differ (P < 0.05). 
xyMeans within a row with different superscripts differ (P < 0.10). 
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Table 3.12.  Effect of dietary treatments and uterine horn nested within diet on fetal weight and placental characteristics  
 Treatments  P value 
Trait CON LL HL PUL SE Horn(trt)2 
No. of litters 7 6 7 7 - - 
No. of mice 59 43 48 58 - - 
Fetal weight, g     0.04 <0.01 
   Right 1.02ab 0.94a 0.95a 1.08b   
   Left 1.01 0.95 0.97 1.02   
Placental weight, g     0.009 0.12 
   Right 0.234 0.243 0.235 0.243   
   Left 0.246 0.245 0.253 0.253   
Placental efficiency1     0.27 <0.01 
   Right 4.51x 3.96y 4.07xy 4.59x   
   Left 4.24 3.98 3.84 4.12   
Labyrinth area, mm2     0.23 0.33 
   Right 5.19 5.19 5.14 4.79   
   Left 4.93 4.77 5.18 5.25   
1Placental efficiency = (fetal weight / placental weight). 
2 Effect of uterine horn nested within dietary treatment. 
abMeans within a row with different superscripts differ (P < 0.05). 
xyMeans within a row with different superscripts differ (P < 0.10). 
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Table 3.13.  Effect of dietary treatment and measurement day on pup weight 
 Treatments  P value 
Trait CON LL HL PUL SE Trt1 Born2 Trt*Born3 
No. pups on D19 40 55 61 53     
No. pups on D18 59 43 48 58     
Weight, g     0.03 < 0.01 < 0.01 0.03 
   D19 1.37a 1.32ab 1.26b 1.33ab     
   D18 1.01ab 0.94bc 0.95b 1.05a     
1Dietary treatment of dam. 
2Day of measurement: D19 = within 24 hours after birth; D18 = gestational day 18. 
3Interaction between dietary treatment of dam and day of measurement. 
abMeans within a row with different superscripts differ (P < 0.05). 
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Table 3.14.  Effects of dam dietary treatment on measures of variation in each litter 
 Treatments   
Trait CON LL HL PUL SE P value 
Within litter birth weight CV1, % 6.91 8.09 7.63 6.93 0.81 0.69 
Within litter wean weight CV2, % 12.97 11.61 10.56 9.90 1.15 0.33 
Pup weight1, g       
   SD3 0.080 0.094 0.087 0.084 0.011 0.83 
   Range4 0.231 0.280 0.241 0.256 0.035 0.77 
   Lower half5 0.136 0.165 0.142 0.138 0.029 0.87 
Wean weight2, g       
   SD 1.52 1.25 1.30 1.02 0.15 0.24 
   Range 4.10 3.29 3.65 2.90 0.39 0.25 
   Lower half 2.04 1.63 1.93 1.75 0.27 0.61 
Body weight of pups at 8 weeks2, g       
   SD 2.58 1.98 2.60 2.85 0.28 0.18 
   Range 6.47ab 5.04b 6.81ab 8.13a 0.70 0.04 
   Lower half 4.14 2.76 3.23 4.71 0.63 0.15 
1No. of litters: CON = 13; LL = 14; HL = 15; PUL = 14. 
2No. of litters: CON = 6; LL = 7; HL = 8; PUL = 7. 
3Standard deviation within litter. 
4The difference between the heaviest and the lightest pup of each litter. 
5The difference between the median and the lightest pup of each litter. 
abMeans within a row with different superscripts differ (P < 0.05). 
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Table 3.15.  Effects of dam dietary treatment in gestation on measures of variation in litters with a minimum of 8 
pups1 
 Treatments   
Trait CON LL HL PUL SE P value 
Within litter birth weight CV2,3, % 7.12 8.42 8.94 7.21 1.33 0.71 
Within litter wean weight CV3, % 10.47 9.71 13.30 10.53 1.00 0.13 
Pup weight3, g       
   SD4 0.075 0.101 0.107 0.085 0.016 0.48 
   Range5 0.229 0.332 0.312 0.279 0.056 0.59 
   Lower half6 0.133 0.221 0.203 0.130 0.046 0.40 
Wean weight4, g       
   SD 1.10 1.07 1.41 1.04 0.11 0.10 
   Range 2.83 3.14 4.13 2.90 0.36 0.08 
   Lower half 1.02 1.62 2.03 1.98 0.42 0.23 
Body weight of pups at 8 weeks4, g       
   SD 2.27 2.17 2.74 2.62 0.35 0.61 
   Range 5.51 5.59 7.51 7.36 0.94 0.35 
   Lower half 3.71 3.80 3.80 4.24 0.66 0.92 
1Litters containing 8 pups or more were used for this analysis. 
2Contains birth weights and fetal weights from pups euthanized at gestational day 18. 
3No. of litters: CON = 8; LL = 5; HL = 6; PUL = 8. 
4No. of litters: CON = 2; LL = 3; HL = 5; PUL = 4. 
5Standard deviation. 
6The difference between the heaviest and the lightest pup of each litter. 
7The difference between the median and the lightest pup of each litter. 
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Table 3.16. Effects of dam gestational dietary treatment on overall post-weaning growth 
performance of offspring 
 Treatments  
Trait CON LL HL PUL SE P value 
No. of litters      6       8        8       7    - - 
No. of mice 40 55 61 53 - - 
No. of cages 13 17 20 17 - - 
   ADG, g 0.34 0.31 0.32 0.34 0.02 0.12 
   ADFI, g 2.75 2.73 2.53 2.81 0.17 0.24 
   G:F 0.12 0.12 0.12 0.12 0.01 0.54 
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Table 3.17.  Effect of dam dietary treatment on post-weaning performance of offspring 
 Treatments  P value 
Trait CON LL HL PUL SE Trt1 Time2 Trt*Time3 
No. of litters 6 8 8 7 - - - - 
No. of mice 40 55 61 53 - - - - 
No. of cages 13 17 20 17 - - - - 
Avg. body weight, g     0.50 < 0.01 < 0.01 0.08 
   Weaning 10.87ab 11.37a 11.27a 10.16b     
   Week 1 13.37ab 14.35a 12.53b 14.06a     
   Week 2 17.34ab 17.71a 16.74b 17.19ab     
   Week 3 19.19ab 19.61a 18.50b 18.73ab     
   Week 4 20.65ab 20.91a 19.73b 20.24ab     
Avg. daily gain, g     0.07 0.94 < 0.01 0.02 
   Week 1 0.61b 0.68b 0.59b 0.75a     
   Week 2 0.62a 0.53ab 0.62a 0.47b     
   Week 3 0.31 0.32 0.27 0.24     
   Week 4 0.21 0.24 0.20 0.24     
Avg. daily feed intake, g     0.16 0.14 < 0.01 0.68 
   Week 1 2.45 2.51 2.21 2.59     
   Week 2 3.25 3.14 3.01 3.11     
   Week 3 2.98ab 3.32a 2.94b 3.27ab     
   Week 4 3.39 3.16 3.16 3.18     
G:F     0.04 0.10 < 0.01 0.29 
   Week 1 0.27ab 0.22b 0.34a 0.33a     
   Week 2 0.19ab 0.16ab 0.22a 0.14b     
   Week 3 0.12 0.08 0.10 0.06     
   Week 4 0.07 0.06 0.07 0.06     
1Dietary treatment of dam 
2Week post-weaning 
3Dam dietary treatment by week post-weaning interaction 
abMeans within a row with different superscripts differ (P < 0.05). 
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Table 3.18. Effect of sex on post-weaning performance of offspring 
 Sex  P value 
Trait Male Female SE Sex Time1 Sex*Time2 
No. of mice 125 84 - - - - 
No. of cages 38 29 - - - - 
Avg. body weight, g 0.43 < 0.01 < 0.01 < 0.01 
   Weaning 11.15 10.69     
   Week 1 14.26a 12.89b     
   Week 2 18.45a 16.05b     
   Week 3 20.89a 17.13b     
   Week 4 22.71a 18.06b     
Avg. daily gain, g   < 0.01 < 0.01 0.35 
   Week 1 0.74a 0.52b 0.07    
   Week 2 0.63a 0.49b     
   Week 3 0.38a 0.19b     
   Week 4 0.28a 0.17b     
Avg. daily feed intake, g  0.13 < 0.01 < 0.01 0.04 
   Week 1 2.38 2.48     
   Week 2 3.27a 2.98b     
   Week 3 3.25a 3.00b     
   Week 4 3.47a 2.97b     
G:F 0.03 < 0.01 <0.01 0.25 
   Week 1 0.34a 0.24b     
   Week 2 0.20 0.16     
   Week 3 0.12a 0.06b     
   Week 4 0.07 0.05     
1Dietary treatment of dam 
2Dam dietary treatment by sex interaction 
abMeans within a row with different superscripts differ (P < 0.05). 
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Table 3.19. Interaction of sex, dam dietary treatment during gestation, and weeks post-weaning on offspring growth performance 
 Treatment      
 CON LL HL PUL      
 Sex  P value 
Trait Male Female Male Female Male Female Male Female SE Trt1 Sex Time2 T*S*Time3 
No. of 
mice 
25 15 37 18 30 31 33 20 - - - - - 
No. of 
cages 
7 5 11 6 10 10 10 7 - - - - - 
Avg. body weight, g 0.60 < 0.01 < 0.01 < 0.01 0.95 
  Wean 11.20ab 10.55b 11.32ab 11.44ab 11.97a 10.57b 10.12b 10.20b      
  Wk 1 14.28ab 12.46cd 14.86a 13.84abc 13.50bc 11.56d 14.43ab 13.70abc      
  Wk 2 18.59a 16.08cd 18.65a 16.77bc 18.09ab 15.39d 18.45a 15.94cd      
  Wk 3 21.17a 17.21bc 21.23a 18.00b 20.44a 16.56c 20.70a 16.75bc      
  Wk 4 23.05a 18.25bc 22.81a 19.00b 21.99a 17.49c 22.98a 17.50bc      
Avg. daily gain, g 0.08 0.94 < 0.01 < 0.01 0.79 
  Wk 1 0.74ab 0.48cd 0.65bc 0.52cd 0.75ab 0.44d 0.84a 0.66abc      
  Wk 2 0.67a 0.57ab 0.59ab 0.47bc 0.66a 0.58ab 0.60ab 0.34c      
  Wk 3 0.42a 0.21bcd 0.42a 0.23bcd 0.34abc 0.20cd 0.35ab 0.14d      
  Wk 4 0.26ab 0.16ab 0.28ab 0.19ab 0.25ab 0.15b 0.34a 0.15b      
Avg. daily feed intake, g 0.21 0.14 < 0.01 < 0.01 0.15 
  Wk 1 2.22bc 2.69ab 2.71ab 2.31abc 2.45abc 1.98c 2.21bc 2.97a      
  Wk 2 3.41a 3.09ab 3.18ab 3.09ab 3.17ab 2.85b 3.31ab 2.91ab      
  Wk 3 3.04ab 2.92b 3.48a 3.15ab 3.09ab 2.79b 3.51a 3.02ab      
  Wk 4 3.54ad 3.23abcd 3.39abd 2.94abc 3.42ad 2.89bc 3.53d 2.83c      
G:F 0.05 0.10 < 0.01 < 0.01   0.74 
  Wk 1 0.36a 0.17d 0.22cd 0.22cd 0.35ab 0.32ac 0.41a 0.25bcd      
  Wk 2 0.19ab 0.18ab 0.18ab 0.14ab 0.23a 0.21a 0.18ab 0.10b      
  Wk 3 0.16a 0.07ab 0.10ab 0.06ab 0.13ab 0.08ab 0.09ab 0.03b      
  Wk 4 0.08 0.06 0.07 0.06 0.08 0.06 0.08 0.04      
92 
 
1Dietary treatment of dam 
2Week post-weaning 
3Interaction of sex, dam dietary treatment during gestation, and weeks post-weaning 
abcdMeans within a row with different superscripts differ (P < 0.05). 
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Table 3.20.  Effect of dam dietary treatment on body composition of offspring 
 Treatments  P value 
Trait CON LL HL PUL SE Trt1 Time2 Trt*Time3 
No. of litters 6 8 8 7 - - - - 
No. of mice 40 55 61 53 - - - - 
No. of cages 13 17 20 17 - - - - 
Avg. body weight, g     0.41 < 0.01 < 0.01 0.65 
   5 weeks 15.21b 15.93a 14.45c 15.42ab     
   8 weeks 20.38b 21.29a 20.03b 20.45b     
Lean mass, %     0.74 < 0.01 < 0.01 0.45 
   5 weeks 91.81ab 90.79b 92.10a 90.92b     
   8 weeks 87.58ab 86.86b 88.58a 87.95ab     
Fat mass, %     0.31 0.03 0.02 0.44 
   5 weeks 7.81 7.86 7.34 7.32     
   8 weeks 7.91ab 8.28a 8.07ab 7.52b     
Total water, %     0.74 0.05 < 0.01 0.68 
   5 weeks 70.21 69.36 70.35 70.26     
   8 weeks 65.85ab 65.36b 66.43ab 67.03a     
1Dietary treatment of dam 
2Week post-weaning 
3Dam dietary treatment by week post-weaning interaction 
abMeans within a row with different superscripts differ (P < 0.05). 
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Table 3.21. Effect of sex on body composition of offspring 
 Sex  P value 
Trait Male Female SE Sex Time1 Sex*Time2 
No. of mice 125 84 - - - - 
No. of cages 38 29 - - - - 
Avg. body weight, g 0.24 < 0.01 < 0.01  <0.01 
  5 Weeks 15.99a 14.51b     
  8 Weeks 22.98a 18.10b     
Lean mass, % 0.68 0.68 < 0.01 0.20 
  5 Weeks 91.29 91.53     
  8 Weeks 87.51 87.98     
Fat mass, % 0.17 0.98 0.02 < 0.01 
  5 Weeks 7.27b 7.89a     
  8 Weeks 8.25a 7.64b     
Total water, % 0.71 0.53 < 0.01 0.63 
  5 Weeks 70.22 69.87     
  8 Weeks 66.19 66.14     
1Dietary treatment of dam 
2Dam dietary treatment by sex interaction 
abMeans within a row with different superscripts differ (P < 0.05). 
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Table 3.22.  Interaction of sex, dam dietary treatment during gestation, and week of age on body composition of offspring 
 Treatment      
 CON LL HL PUL      
 Sex  P value 
Trait Male Female Male Female Male Female Male Female SE Trt1 Sex Time2 T*S*Time3 
No. of 
mice 
25 15 37 18 30 31 33 20 - - - - - 
No. of 
cages 
7 5 11 6 10 10 10 7 - - - - - 
Avg. body weight, g 0.51 < 0.01 < 0.01 < 0.01 0.83 
  5 Wks 15.86abc 14.56d 16.55a 15.32bcd 15.66bc 13.23e 15.91ab 14.93cd      
  8 Wks 22.70a 18.06bc 23.47a 19.10b 22.84a 17.22c 22.90a 18.01c      
Lean mass, % 0.84 < 0.01 0.68 < 0.01 0.12 
  5 Wks 91.75ab 91.88ab 91.29b 90.29b 91.31b 92.90a 90.80b 91.05b      
  8 Wks 87.46bc 87.71abc 87.52bc 86.21c 89.22a 87.94ab 87.72abc 88.19ab      
Fat mass, % 0.44 0.03 0.99 0.02 0.54 
  5 Wks 7.43bc 8.19ab 7.35bc 8.36a 7.00c 7.68abc 7.31bc 7.34bc      
  8 Wks 8.26a 7.57ab 8.12a 8.44a 8.21a 7.93a 8.42a 6.62b      
Total water, % 0.91 0.05 0.53 < 0.01 0.19 
  5 Wks 70.64 69.77 70.03 68.69 70.35 70.35 69.77 70.66      
  8 Wks 65.45b 55.25ab 65.42b 65.31b 67.36a 65.50b 66.55ab 67.51a      
1Dietary treatment of dam 
2Week post-weaning 
3 Interaction of sex, dam dietary treatment during gestation, and weeks post-weaning 
abcdMeans within a row with different superscripts differ (P < 0.05). 
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Table 3.23.  Comparisons between the mouse and the sow 
Trait  Mouse Sow 
Age of sexual maturity 6-8 weeks of age 160-220 days of age 
Length of gestation 19-21 days 113-115 days 
Length of lactation 21-28 days 21 days 
Litter size 4-12 12-14 
Within-litter birth weight CV,% 10%1 19%2 
Placental type Discoid3 Diffuse4  
Nutrient exchange mechanism Counter-current system5 Cross-current system6 
Number of teats 10 (5 pairs) 12-14 (6-7 pairs) 
1Value is inherent variation only, genetically identical mice housed in environmentally 
controlled rooms. 
2Value includes genetic, environmental and inherent variability. 
3A placenta where chorionic villi are arranged in a circular plate. 
4A placenta made up of villi diffusely scattered over almost the whole surface of the 
chorion. 
5The maternal and fetal blood flows in opposite directions with vessels parallel to each 
other and is the most efficient nutrient exchange system. 
6The maternal and fetal blood vessels cross each other creating one point of contact for 
nutrient exchange. 
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Chapter 4 
Conclusion 
 Genetic selection has resulted in an increase in litter size in sows. Increased litter 
size has also been accompanied with an increase in pre-weaning mortality. The increase 
in pre-weaning mortality that has been observed on sow farms today can potentially be 
due to an increase in within-litter birth weight variation by increasing the incidence of 
low birth weight pigs as a result of intrauterine growth retardation (IUGR). Intrauterine 
growth retardation has permanent negative effects on animals such as increased pre-
weaning mortality, slower growth, reduced feed efficiency, fatter carcasses and poorer 
meat quality, and impaired long-term health. The increase in IUGR and low birth weight 
pigs increases production cost compared with their normal birth weight littermates and 
therefore, reduces the production efficiency of farms. 
 Many factors can affect birth weight, but the two main factors are placental 
development and maternal nutrition during gestation. Fetal growth depends on placental 
growth and efficiency which is directly related to the functional efficiency of the placenta 
in delivering nutrients and oxygen to the fetuses. Suboptimal maternal nutrition during 
gestation leads to the inability to provide the correct amount of nutrients. Researchers 
have evaluated interventions that may increase birth weight, but few have investigated 
approaches to potentially reduce within-litter birth weight variation. Interventions that 
have already been researched include exogenous growth hormone administration, a 
feeding practice known as “bump feeding”, and supplementation of amino acids, such as 
arginine or glutamine, during several periods of gestation. These interventions have had 
mixed effects in sows and gilts for increasing litter weight, birth weight, and reducing 
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variation in birth weight. Administration of growth hormone appeared to improve fetal 
weight, placental growth, and selectively improved uterine environment for smaller 
piglets. However, growth hormone administration is not an approved practice in the U.S. 
swine industry. Therefore, if an intervention can be found that naturally increases 
endogenous growth hormone, it may be effective in combating the incidence and effects 
of IUGR and low birth weight pigs. 
 The leucine metabolite, β-hydroxy-β-methylbutyrate (HMB), has been studied 
briefly in pigs. Three sow studies reported increases in birth weight with HMB 
supplementation during various stages of gestation with one report that documented 
HMB reduced the percentage of low birth weight pigs. β-hydroxy-β-methylbutyrate can 
increase endogenous levels of growth hormone in animals as well as increase weaning 
weights, market weights, and improve carcass quality in swine. Similar results have been 
observed in other species. It was our assumption that HMB acts directly on the fetus, 
however, it is unknown if HMB can act directly on the fetus by crossing the placenta or 
indirectly by affecting placental development and function. 
 The goal of the research presented in this thesis was to determine if HMB could 
reduce within-litter birth weight variation and improve growth performance in mice. 
Mice were chosen to serve as a less expensive surrogate model for sows. We found that 
diet supplementation of HMB to mouse dams during gestation had no effects on birth 
weights, within-litter birth weight variation, weaning weight, or growth performance and 
body composition of offspring after weaning. Maternal diet supplementation of HMB 
during gestation also had no effects on placental weight and labyrinth area but reduced 
placental efficiency ratio at the low level when fed to dams at 3.5 mg/g diet. More 
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research is needed to determine if HMB is effective in reducing variation in birth weight 
and growth performance of offspring in food animals. One of the first areas that needs to 
be explored is whether HMB crosses the placenta to determine if the observed effects are 
from a direct response of HMB on the fetus or indirectly by affecting placental 
development and function. Other areas of research that need to be explored are 
determining the most effective dose of HMB to administer and during which time points 
during gestation it should be supplemented to obtain positive results.  
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